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     The quinoline ring system is a common structural component of a wide variety of 
natural products with highly desirable biological activity, including antimalarial 
agents such as quinine, chloroquine and mefloquine, as well as antitumor agents such 
as dynemicin A, luotonin A, and camptothecin.  The synthesis of the highly effective, 
yet prohibitively toxic, antitumor antibiotic streptonigrin is targeted in this research.  
A concise, convergent synthesis of this antitumor agent will pave the way for an 
expeditous survey of streptonigrin analogues that have similar pharmaceutical value 
with diminished toxicity.  Our retrosynthetic plan required the development of new 
methodology to form the heterocyclic ring of quinoline, in a manner that would allow 
the utilization of palladium-catalyzed coupling of complex aryl triflates to form the 
tetracyclic structure of this highly functionalized natural product. 
  
     A method has been developed to synthesize complex, substituted quinolines in a 
facile manner through the utilization of o-nitrophenyl propargyl alcohols.  Through 
either direct lithium acetylide addition of available alkynes, or Sonogashira coupling  
to terminal propargyl alcohols, the assembly of complex internal propargyl alcohols 
has directly lead to 2-aryl-, 2-alkenyl and 2-alkylquinolines via reductive cyclization 
under mildly acid conditions.  This reductive cyclization takes advantage of the facile 
Meyer-Schuster rearrangement of resonance-stabilized o-anilinopropargyl alcohols to 
o-aminochalcones, which cyclize to quinoline in a one-pot procedure. 
     This work has also examined the use of this reductive cyclization to form 2-
pyridylquinolines, however such cyclization has repeatedly led to the 4-quinolone.  
The mechanism of such an anomalous cyclization has been studied. Although the 
mechanism has not been definitively identified, several potential pathways have been 
examined, with evidence favoring an acid-catalyzed, non-Meyer-Schuster 
rearrangement of the propargyl alcohol leading to cyclization and oxidative 
rearomatization to form the observed quinolone.   
     Lastly, reductive cyclization has been applied to model systems for the ABC-ring 
system of the natural product streptonigrin.  The synthesis of an appropriate A-ring 
precursor o-mononitrobenzaldehyde has been achieved, and elaborated to the final 
6,8-dimethoxy-2-(2’-pyridyl)quinolone through reductive cyclization.  A more 
intriguing A-ring precursor dinitrobenzaldehyde, with built-in functionality to 
produce streptonigrin’s 7-amino group, was also targeted.  Efforts toward its 
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     This manuscript details progress in the DeShong research group toward the total 
synthesis of the antitumor, antibiotic natural product streptonigrin (1) (Figure 1).  
Previous work in the DeShong group conducted by Dr. William McElroy produced a 
late stage CD ring pyridyl triflate intermediate (2),1,2 that incorporated the 
functionality of the natural product.  In order to complete the synthesis of 
streptonigrin from intermediate 2 in a convergent and efficient manner, we have 
developed a new synthetic route to 2-arylquinolines, similar to the structure of the AB 
ring system of streptonigrin.  Although this heteroannulation of quinoline was 
developed specifically to apply to the synthesis of streptonigrin, the methodology can 
be utilized for the synthesis of a wide variety of 2- and 2,4-substituted quinolines, 



























Figure 1.  Streptonigrin (1) and McElroy’s Intermediate (2) 
 
     The following introductory material will survey the wealth of research directed 




more recent modifications that have dominated quinoline research, placing this new 
work into the context of those past syntheses.  Also, a vital component of our 
proposed mechanism for this synthesis utilizes the facile rearrangement of propargyl 
alcohols to !,"-unsaturated enones--the Meyer-Schuster rearrangement.  Therefore, a 
short review of the history, mechanistic studies and applications of that rearrangement 
is provided.  Lastly, the significance of a new synthetic route to streptonigrin is 
established through a summary of both its pharmaceutical value and the few elegant, 
yet lengthy, past total syntheses of this important natural product. 
 




Heteroannulation – Formation of Quinolines 
     The quinoline ring system has been heavily studied as a synthetic target since its 
discovery by Gerhardt in 1842.3 Although some synthetic work has been directed 
toward organic materials and dyes, the lion’s share of quinoline research has been 
focused on pharmaceuticals.  A few of the major targets have included treatments for 
parasitic infections such as malaria and leishmaniasis, as well as antitumor agents 
such as streptonigrin (1),4,5 dynemicin A (2),6,7 luotonin A (3),8 and camptothecin (4)9 
(Figure 2).  Along with those formidable targets, natural product isolations and 
biological activity assays continue to identify new, potentially useful quinoline 
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     The early work on quinolines was clearly guided toward the fight against 
malaria—a fight that still rages today.  Despite centuries of work on quinine (5), its 
asymmetric synthesis was only recently achieved by Stork.21 Stork’s process did not 
represent a novel quinoline ring synthesis—he used 6-methoxy-4-methylquinoline as 
a starting material.  However, the longtime goal of a stereospecific quinine synthesis 
highlights the continued need for quinoline-based antimalarial agents.  According to 
the World Health Organization, malaria’s annual death toll is estimated at 1-3 million 
people, mostly in young sub-Saharan African children.  Treatments have focused on a 
class of aryl aminoalcohols, including quinine (5), quinidine (6), mefloquine (7), 









































     The synthesis of new quinolines has played a critical role this fight.  Various 
substituted quinolines have been developed over the years to treat Plasmodium 
falciparum, the most virulent protozoa involved in the spread of malaria.  However, 
P. falciparum has proven itself formidable, growing resistance to each new treatment.   
The first such treatment, quinine (5), was introduced in the 19th century but 
resistance was found in 1910.  Chloroquine (9), brought into the fight in 1945, was 
effective for a time but in 1957 chloroquine-resistant strains were discovered.  In the 
late 1970s, subsequent screening for effective analogues of chloroquine identified 
mefloquine (7).  But yet again, mefloquine-resistant strains were quickly identified.  
Recently, a new aminoquinoline AQ-13 (8), has been screened as a potent agent in 
otherwise resistant strains of P. falciparum.23 This new quinoline target will be used 
in conjunction with a newer class of antimalarial agents, derived from the non-
quinoline-based natural product artemisinin.  This combination therapy is hoped to be 
effective against resistant strains of P. falciparum. 
     Excellent reviews of the synthesis of quinoline systems have been written as early 
as 1942, by R. Manske,3 and as recently as 2005 by Kouznetsov.24 For the sake of 
brevity, this review will not attempt to thoroughly cover the enormous volume of 
work on synthesizing quinolines in the past 150 years.  This summary will survey the 
recent work done in the field, focusing on new techniques to generate quinoline’s 
heterocyclic ring, referencing the classical syntheses only when necessary to set the 
tone of the current work.   
     In order to categorize each of the new quinoline synthesis techniques, it is 




wealth of named reactions used to generate the quinoline ring system.  Those named 
reactions can be broken down into two classes based on the substitution pattern of the 
starting materials.24 Those that begin with unsubstituted anilines include the Skraup, 
Doebner-von Miller, Conrad-Limpach-Knorr, and Combes syntheses.  Those that 
begin with ortho-substituted anilines include the Friedländer, Pfitzinger, 
Niemantowski and Borsche syntheses.  Although each technique has its own set of 
advantages and limitations, the Skraup and Friedländer work set the baseline for all 
other variations.    
 
SKRAUP AND SKRAUP-LIKE TECHNIQUES 
     The Skraup, Doebner-von Miller, Conrad-Limpach-Knorr and Combes syntheses 
each start with aniline as the nucleophilic nitrogen component, and vary in the 
additional electrophilic 3-carbon piece added (Scheme 1).    In the Skraup synthesis,25 
aniline was heated with glycerin, sulfuric acid and an oxidizing agent, such as 
nitrobenzene, to form quinoline.  Doebner and von Miller26 substituted 1,2-glycols or 
!,"-unsaturated aldehydes for the glycerine, to condense with the aniline to form the 
same pyridinoid ring.  The Conrad-Limpach-Knorr reaction used acetoacetic 








































Conrad-Limpach-Knorr Synthesis  
 
     The mechanism of the Skraup/Doebner von Miller syntheses was quite 
controversial.  Skraup’s proposed mechanism was based on producing Schiff base 
intermediate 12 (Scheme 2), which directly cyclized with the aromatic ring.  
However, this could not explain the regiochemistry found using !,"-unsaturated 
aldehydes, which led exclusively to 2-substituted quinolines.30 In 1892, Bischler 
proposed a mechanism that involved the 1,4-addition of aniline with Skraup’s Schiff 




































     Eisch’s work used the hydrochlorides of cinnamaldehyde anil (13) and N-(p-
methylcinnamylidene)-p-toluidine (14), under strictly anhydrous conditions, and 
observed an exchange reaction, leading to a mixture of four Schiff bases ( 












































     Eisch also measured the rate of disappearance of cinnamaldehyde anil 
















     Combining these observations, Eisch proposed a diazetidinium cation intermediate 
(Scheme 5).  This proposal agreed with his first-order kinetic data, since the second 
molecule of anil is regenerated in the process.  This proposed mechanism also 

















































     A recent study reported by Matsumoto and Ogura32 followed a similar mechanistic 
pathway.  Tosylenamines, formed in situ by the hydrogen iodide reduction of 2-
(arylamino)-1-(methylthio)1-tosylethenes, dimerize to form an imine capable of 
electrophilic ring closure, which after aniline elimination and oxidation, formed 3-































   
     In an attempt to further elucidate the mechanism of the Skraup/Doebner von 
Miller quinoline synthesis, Denmark conducted a series of isotopic labeling 
experiments cyclizing p-isopropylaniline with mesityl oxide 13C-labeled once at the 
2-position or labeled at both 2- and 4-positions.33 The 13C(2)-mestiyl oxide 
experiment led to a quinoline product with 13C-enrichment at both possible positions 

















= 13C label  
 
This result implied that either (1) multiple mechanistic pathways were simultaneously 
operative, leading to a mixture of labeled quinoline products, (2) the mesityl oxide 
acetone subunits were scrambling during the cyclization, or (3) mesityl oxide was 
scrambling prior to and separate from the cyclization process.  Control experiments 
led Denmark to conclude that the impact of mesityl oxide scrambling outside of the 
cyclization process (option 3) was minimal.  Denmark next ran crossover cyclizations  
using a mixture of 13C(2,4)-labeled mesityl oxide and mesityl oxide at natural 
abundance (Scheme 8).  In those reactions, the mass distribution of quinoline was 
enriched in singly labeled (M+1)+ product equal to the extent theoretically expected 
by random scrambling.  Since the retro aldol/aldol scrambling of mesityl oxide itself 
was previously excluded, Denmark concluded that the acetone units of mesityl oxide 
































Further studies by Denmark with a different !,"-unsaturated ketone led to the same 
basic conclusion--although a definitive mechanism was not clearly established, 
Denmark believed the Skraup reaction occurs through a sequence of (1) conjugate 
addition of the aniline to the enone, (2) fragmentation/recombination of the ketone 
segment leading to a new Schiff base, (3) conjugate addition of a second aniline 
molecule, and (4) cyclization and elimination of the first aniline to form quinoline.  
Not unlike Eisch’s rationalization, this proposed mechanistic sequence explained the 
observed regiochemistry of the resulting quinolines produced by the Skraup/Doebner 










































































     Recent applications of the Skraup reaction highlight its utility.  In 2000, Boger 
used a modified Skraup reaction using bromoacrolein in his synthesis of an analogue 




in an acidic solution with a 3-aminocatechol to form the quinoline-7,8-diols needed in 





















Halitulin (15) Methoxatin (16)
Brequinar (18)Cryptolepine (17)  
Figure 4.  More Quinoline-based Natural Product Targets 
 
     The harsh conditions required for these reactions—high temperatures and highly 
acidic medium—have prompted considerable work in modifying the procedure to 
find more mild, yet regiospecific conditions.  In 2002, Theoclitou and coworkers used 
microwaves to shorten the times of Skraup reactions from 60 hours down to 1 hour 
with similar yields.  Since this improvement was not sufficient for their goal of 
developing a combinatorial Skraup synthesis, they also developed a route using 
scandium triflate catalysis.  This improved the yield significantly, and along with the 
microwave assistance, produced the desired Skraup reaction products at room 




     In 1998, Wrobel developed a quinoline synthesis analogous to the Skraup 
synthesis, switching the polarity of the two components.  He used nitroarenes as an 
electrophilic nitrogen source, and cinnamyl phenyl sulfone, which under mildly basic 
conditions, formed a nucleophilic three-carbon unit.  This procedure formed 2-
phenyl-4-phenylsulfonyl-quinolines which could be treated with various nucleophiles 
to undergo SNAr reactions with the phenyl sulfone to generate 2-arylquinolines with a 


























     Ila and coworkers developed a modified Skraup synthesis using 3-
bis(methylthio)acrolein as a “surrogate” acrolein, which was synthesized from vinyl 
acetate (Scheme 11, upper equation)31.  This mild method was an improvement over 
their previous work which used a similar !-oxoketene-N,S-anilinoacetal in a 
regioselective synthesis of functionalized quinolines through Vilsmeier cyclization 
(Scheme 11, lower equation).  Both cyclizations were facile with N,S-acetals bearing 
strongly activating groups on aniline.  The resulting 2-methylthio-quinolines could be 




nucleophiles to generate 2-alkyl, aryl or amino quinolines.38,39 Wang also reported 
using remarkably similar !-aroylketene dithioacetals with o-aminobenzoic acids to 



































     Katritzky demonstrated an improved Vilsmeier-type cyclization using 
benzotriazole iminium salts and N-arylimines.  The resulting vinamidium salts were 
readily transformed into 2- and 3-alkyl quinolines through a tandem cyclization-

























     In 1995, Otto Meth-Cohn reviewed his longstanding “Vilsmeier Approach” and 
described a newer “Reverse Vilsmeier Approach” to quinolines.   The “Vilsmeier 




dimethylformamide to formylate the enamines.  After electrocyclization, the 
























In Meth-Cohn’s “Reverse Vilsmeier Approach.” N-methylformanilide was used to 
form a Vilsmeier reagent, and reacted with electron-rich alkenes.  After reaction with 
a second equivalent of Vilsmeier reagent, cyclization occurred to form N-

































     Focusing solely on the reaction conditions, improvements to the Skraup/Doebner-
von Miller processes have been recently achieved using solid-phase, two-phase, and 
vapour-phase procedures.  In 2003, Ranu et al., reported a microwave-assisted, 
solvent-free Doebner-von Miller synthesis of 4-alkylquinolines.  His conditions 
utilized the aniline and alkyl vinyl ketone adsorbed onto silica gel impregnated with 
indium chloride.  After short microwave irradiation, excellent yields of 4-
alkylquinolines were obtained, using a variety of alkyl, alkoxyl, hydroxyl and halide 
substituted anilines.  This technique was also demonstrated to be effective at making 
alkyldihydroquinolines, using "-disubstituted alkyl vinyl ketones.43,44  Kidwai also 
reported a solid-phase, microwave-assisted synthesis of 2,4-alkylquinolines.  A 
preformed vinylous amide condensed from chlorofluoroaniline and !,"!unsaturated 
methyl ketone was cyclized on acidic alumina, under solvent-free conditions.  This 
led to clean quinoline product without the use of mineral acids or toxic organic 
solvents.45   
     Matsugi and coworkers developed a two-phase protocol for the Doebner-von 
Miller synthesis. Their production of 2-alkyl quinolines was optimized using a 
toluene/6M HCl two-phase reaction medium.  The !,"-unsaturated aldehyde 
remained in the toluene phase, until protonated at the phase interface.  The protonated 
anilines remained in the aqueous phase.  This setup prevented the polymerization of 
the aldehydes which usually plagues the Doebner-von Miller reaction, both in yield, 
and in product isolation.46  Li also reported a two-phase Doebner-von Miller reaction 
using similar conditions.  Li used 12N HCl, toluene, and a phase-transfer catalyst.  In 




the desired 2-methyl-8-quinoline carboxylic acid.47 Similar yield and product 
isolation improvements were noted.    
     Vapour phase protocols for quinoline synthesis have also been reported as an 
improvement to the Skraup synthesis of alkylquinolines.  In 1997, Campanati 
developed a procedure using acid-treated K10 Montmorillonite clay, gasous ethylene 
glycol and 2-ethylaniline.   This heterogeneous catalysis produced 2-methyl-8-
ethylquinoline regioselectively, and also verified the crotonaldehyde intermediate 
proposed by Doebner-von Miller.  Yields were modest, but were reported based on 
the amount of ethylene glycol used, as opposed to that of the aniline starting 
material.48   
     Applications of modified Doebner-von Miller syntheses have also been reported.  
Carrigan reported the application of a process initially reported by Corey (Scheme 
15),49 using dimethyl oxoglutaconate as the three-carbon unit.  This procedure 
produced twenty-six quinoline-2,4-dicarboxylic acids that were subsequently 
screened for activity as inhibitors of glutamate vesicular transport protein.50 Zhang 
also used the Corey modification, using dimethyl oxoglutaconate and a 
3-methoxyaniline.  Instead of the quinoline formation, Zhang observed addition at the 
position para to the amino group.  This product could not cyclize in a Doebner-von 
Miller manner, and was reported as a possible alternative mechanism for the reaction, 
proposing that the benzenoid addition may occur first followed by cyclization.  
However this proposal was specifically caveated by the uniqueness of the substrate 
used, both due to electronics of the electron-rich arene and the sterics of their 





























     Wu recently reported an application of the Skraup/Doebner von Miller reaction 
demonstrating a reversal of the typical regioselectivity.  Condensing #-aryl-",#-
unsaturated !-ketoesters with anilines produced 4-aryl-2-carboxylquinolines (Scheme 
16), not the expected 2-aryl-4-carboxyquinolines.   Wu proposed a direct 1,2-addition 
of the aniline to form an anil which Eisch observed to not cyclize (see top of Scheme 
2).   However, Wu hypothesized that the additional electron-withdrawing nature of 
the ester group facilitated a direct electrophilic ring closure, forming the observed 



















     The use of !-tolylsulfonyl-!,"-unsaturated ketones was demonstrated by Swenson 
to produce 2,4-aryl and alkyl quinolines (Scheme 17).  In this case, the combination 










































     Perfluoroalkylquinolines have been produced, and the mechanism of such a 
cyclization has been studied and reported by Schlosser, et al.54 Perfluoroalkyl-1,3-
dicarbonyls were linked to anilines, and a mechanistic study was conducted to explain 
the production of high yields of the unexpected 2-substituted quinolines (Scheme 18).  
Amine randomization was the explanation for the perceived “walking” of the 






































     Recent applications of modified Conrad-Limpach-Knorr and Combes reactions are 
more rare than that of Skraup and Doebner-von Miller.  In 2003, Schlosser’s group, 
along with the aforementioned mechanistic study, reported on the preparation of a 
range of trifluoromethyl-substituted quinolines, using ethyl trifluoroacetoacetate.  
After subsequent transformations, this Conrad-Limpach-Knorr type, acid-catalyzed 
condensation with anilines produced high yields of the desired trifluoromethyl 
quinoline carboxylic acids.55 In 1996, Nicolaou and coworkers used the Conrad-
Limpach-Knorr reaction in their partial synthesis of the CDE ring of dynemicin A (2).   
In this example, p-anisidine was reacted with diethyl oxalacetate under acidic 
conditions, and thermally cyclized to the desired 2-carboethoxy-4-hydroxyquinoline 



























     In 1998, Charpentier developed a synthesis of 3-cyanoquinolines using 
3,3-dimethoxy-2-formyl-propanenitrile sodium salt as a 1,3-diformyl-2-cyano 
synthon.  This modified Combes procedure initially produced the Z-isomer 19 
(Scheme 20), which would not cyclize.  After optimization, treatment with p-toluene 











































     Lastly, 4-aminoquinolines can be produced from anilines using a procedure 




agents, like chloroquine (9), and are highly desirable synthetic targets.  The key to 
Palacios’ procedure is the addition of lithiated "-enamino phosphonates to 
isocyanates to form the functionalized amides, which when treated with 
triphenylphosphine and hexachloroethane in the presence of triethylamine cyclize to 
the desired 4-aminoquinolines.  The resulting 3-phosphonyl group was also proposed 




























FRIEDLÄNDER AND FRIEDLÄNDER-LIKE TECHNIQUES 
     The second major class of quinoline syntheses start with ortho-substituted anilines, 
and are based on variations of the Friedländer synthesis, including the Pfitzinger, 
Niemantowski and Borsche syntheses.  Since its initial discovery in 1882, the 
Friedländer synthesis is by far the most widely applied, and modified, quinoline 
synthesis to date.59 The basic Friedländer reaction involves the condensation of o-
aminobenzaldehyde or o-amino benzyl ketone with the two carbons derived from an 
!-methylene carbonyl unit.  The major variants of the Friedländer vary not in the 
methylene carbonyl, but in the starting aniline derivative.  The Borsche reaction60 
starts with arylimines, the Pfitzinger reaction61 starts with isatin, and the 



































     Examples of the use of the Friedländer reaction can be found throughout the 
literature.  One of the earlier, notable examples was reported by Bracke.   In 1969, a 
polycondensation of 4,6-diaminoisophthalaldehyde with p-diacetylbenzene, 
2,6-diacetylpyridine, and bis(p-acetyl-phenyl) ether resulted in thermally stable 
anthrazoline polymers.62 In the same time frame, Parfitt reported the synthesis of 
benzo[a]phenanthrolines prepared by a double Friedländer condensation of 
2,2’-diaminobenzophenone with "-diketones.63 In two major natural product 
syntheses published in the early 1980s, Weinreb and Kende both used Friedländer 
reactions to assemble the AB quinoline ring in their synthesis of streptonigrin (1).4,5,64 
These two works will be thoroughly reviewed in a later section.  More recently, the 
synthesis of an inhibitor of HMG-CoA (the rate-limiting enzyme in sterol 
biosynthesis in animals and plants) was conducted by Suzuki, using a Friedländer 
synthesis of the 2-cyclopropyl-4-(p-fluorophenyl)-3-quinoline carboxylic ester 
intermediate.65  This p-toluenesulfonic acid catalyzed condensation produced the 
desired product in 90% yield, and was suitable for the proposed industrial scale up of 
this synthesis.  In 2000, Camps targeted the synthesis of an acetylcholinesterase 
inhibitor, dubbed huprine X, as a potential treatment for Alzheimer’s disease.  This 
synthesis relied on a Friedländer condensation of 4-chloro-2-aminobenzonitrile with 
their previously developed bicyclononenone, to afford the desired bicycloquinoline in 


































     As was seen in the Skraup/Doebner-von Miller syntheses, the Friedländer 
approach has been limited only by the availability of the starting materials, and the 
harshness of the reaction conditions.  Many recent works have focused on improving 
those reaction conditions, including various solvent and solvent-free systems, newer 
catalyst applications, and more robust and versatile starting materials than the 
relatively unstable o-aminobenzaldehydes.   
     Work emerging from the Yadav group at the Indian Institute of Chemical 
Technology has highlighted several examples of such conditions improvements.  In 
1997, solvent-free, clay-catalyzed Friedländer reactions were been developed.   These 
heterogeneous reactions produced yields equivalent to those reported in the literature 
for similar transformations in solvent, with significantly shorter reaction times, and 
cleaner product isolations.67 In 2005, Yadav outlined the use of sulfamic acid as a 
heterogeneous catalyst in Friedländer condensations.  In this solvent-free procedure, 
both cyclic and acyclic alkyl ketones were condensed with o-aminobenzophenones to 




filtration of the solid catalyst and recrystallization of the product necessary for 
purification (Scheme 24).68 Yadav’s group also developed the use of silver 
phosphotungstate as a heteropolyacid catalyst for the Friedländer condensation of 
2-aminobenzophenone with acetyl acetone.  This reaction produced an exceptional 
89% yield, in 4.5 hours.69 Yadav’s group also reported the use of 5 mol % 
bismuth(III) triflate as a catalyst for the same Friedländer reaction, reporting virtually 
the same improvements:  91% yield in 4h, in room temperature ethanol.  This is a 
dramatic improvement over traditional acid-catalyzed reactions that require refluxing 








A, B or C
N
O
A = sulfamic acid 






     As a purported improvement over this Bi(OTf)3 catalysis, De and Gibbs applied 
Y(OTf)3 as a catalyst in a similar condensation of o-aminobenzophenone with ethyl 
acetoacetate, reporting 89% yield in 4h in room temperature acetonitrile.71  In 2003, 
Arcadi reported the use of gold(III) catalysts in a “green” approach to the Friedländer 
synthesis.  By using 2.5 mol % of NaAuCl4•2H2O in ethanol at 40 °C, the 
condensation of o-aminobenzophenone with ethylacetoacetate was completed in 6h 
with an 83% yield.72 Most recently, in 2007, Zhang and Wu outlined a “Lewis acid-




tris(dodecyl sulfate),73 and Dabiri reported a solvent-free Friedländer synthesis 
catalyzed by oxalic acid.74  
     Along with improved catalysts, the Friedländer synthesis has been extensively 
modified by numerous investigators to improve the yield, and limit the byproducts of 
this sequence.  Kadin reported a relatively early example of such a modification in 
1984, where o-nitrobenzaldehydes were used as starting material, based on their 
easier preparation and storability over o-aminobenzaldehydes.  Kadin used a modified 
Wittig reaction to convert o-nitrobenzaldehydes to o-nitrobenzyl alkenes, which 
cyclize to produce quinoline-2,3-dicarboxylate N-oxides.   After reduction of the N-
oxide, the desired quinoline-2,3-dicarboxylates are isolated in moderate yields.75  
Another novel route to quinoline synthesis involved starting with nitro aryl aldehydes, 
and reducing the nitro group to aniline in situ, in the presence of the enolizable 
carbonyl compound.  McNaughton proved that strategy successful by using a 
combination of 5 eq each of SnCl2 and ZnCl2.  This combination reduced the nitro 
group of o-nitrobenzaldehyde, and in the presence of various symmetrical ketones, 
produced the desired 2,3-alkylquinolines in high yield (82-94%) (Scheme 25).76  This 
approach was mirrored by Li in 2007 using Fe/HCl as the reducing agent, producing a 
















    In two recent reports by Cho, o-aminobenzaldehydes were also produced in situ, by 
the catalytic oxidation of o-aminobenzyl alcohols (Scheme 26).  In the presense of a 
variety of ketones, 2- and 2,3-substituted quinolines were produced by this modified 














     With the goal of improving the breadth of products available, Na et al. introduced 
a Friedländer variation that used N-phenyl enaminones and alkyl anhydrides as the 
starting materials.  This reaction allowed the creation of 4-alkyl-2,3-carbocyclic 
quinolines, where the new 2,3-carbocycle was derived from the original enaminone, 



































     Muchowski and coworkers achieved a widely referenced modification to the 
Friedländer reaction, by condensing ortho-lithiated Boc- and Piv- protected anilines 
with 4 different masked malondialdehydes derivatives to produce 3-aryl and alkyl 
substituted quinolines in good to excellent yield (Scheme 28).  This approach 
benefited from the ease of producing N-acylarylamines, the ready availability of the 




















































     Two recent papers by Ubeda and Chelucci applied this ortho-lithiated aniline 
strategy in a similar manner, however they both first used DMF to formylate the 




form quinolines.  Ubeda used a variety of aryl and alkyl ketones and aldehydes in the 
second step, but had better success with the ketones, forming 2,3-alkyl and aryl 
quinolines in good yield.  Forming 3-unsubstituted quinolines using enolized 
aldehydes were less successful, due to noted secondary reactions.  Ubeda’s procedure 
also benefited from facile N-deprotection of the pivaloyl group.82  In the work of 
Chelucci, Boc-protected anilines were similiarly ortho-lithiated with t-BuLi and 
formylated with DMF, to produce the Friedländer-esque o-aminobenzaldehydes.  
Those intermediates were not isolated, but immediately treated with the enolates of 
various ketones, and refluxed in 3N HCl to produce the desired alkyl and aryl 
quinolines in varied yields (29-85%).83   
     The Pfitzinger reaction is also a widely used variation of the Friedländer reaction, 
using isatin derivatives instead of o-aminobenzaldehydes.   As early as 1954, Henze 
investigated the regioselectivity of the Pfitzinger reaction using unsymmetrical alkyl 
ketones.61 In 1982, Weinreb applied the Pfitzinger reaction to the synthesis of 
methoxatin (16) (Figure 4), a coenzyme in several bacterial alcohol dehydrogenases.  
The Pfitzinger reaction of 6,7-dimethoxy-5-methyl isatin with pyruvic acid under 
basic conditions (using KOH), afforded the desired diacid (Scheme 29), which was 
immediately converted to the diester, with an overall 50% yield for the two steps.  
Subsequent transformations, including an "umpolung" variation of the Reissert indole 
synthesis for annulation of the remaining pyrrole ring, afforded methoxatin (13) in 13 

























     Other examples of the application of the Pfitzinger reaction include two 
publications by Deady and coworkers, in the synthesis of new topoisomerase I and II 
inhibitors.  The work focused on making new non-linear tetracyclic quinolines with 
inhibitory activity similar to doxorubicin and DACA.   The synthesis of these putative 
inhibitors was conducted using Pfitzinger reactions of isatin-7-carboxylic acid with 
various substituted 1-indanones, in a 10% NaOH solution for 1h (Scheme 30).  
Although the bulk of the data focused on structure-activity evaluations, the 















     In 2001, Wright and coworkers reported the use of the Pfitzinger reaction to 
synthesize 15 derivatives of the indoloquinoline alkaloid cryptolepine (17) (Figure 4).  
These derivatives were hoped to lack the DNA intercalating cytotoxicity of 
cryptolepine, while retaining the chloroquine-like antiplasmoidal properties that make 




acetylindoxyl in the presence of KOH under oxygen-free conditions to produce 


















     Ivachtchenko’s work in 2004 demonstrated both a utilization and mechanistic 
study of a unique product observation in the Pfitzinger reaction.  Using 5-
sulfamoylisatins and diethyl malonate, their Pfitzinger reaction produced 6-
sulfamoyl-4-quinoline carboxylic acids, instead of the anticipated 2-oxo-1,2-
dihydroquinoline-4-carboxylic acid.  Their mechanistic studies including isotopic 
labeling and dynamic LCMS measurements proved that the ethanol co-solvent was 
incorporated into the new quinoline ring system instead of the methylene from the 
diethyl malonate.  Using 13C labeling of both the ethanol and diethyl malonate, in 
separate experiments, they were able to clearly identify the ethanol carbon in the 
quinoline ring.88   
     Finally, Boa reported the use of the Pfitzinger reaction to generate a series of 2-
phenyl-quinoline-4-carboxylic acid derivatives, related to the human dihydroorotate 
dehydrogenase (DHODH) inhibitor brequinar (18) (Figure 4).   The malarial parasite 
P. falciparum does not have the ability to salvage pyrimidines and relies on the de 
nuovo synthesis of uridine monophosphate to grow.  One of the enzymes required in 




become favorable targets in the search for new antimalarial chemotherapies.  
Brequinar is a known inhibitor of the human DHODH, and was used a baseline for 
designing P. falciparum DHODH inhibitors.  The series of brequinar analogues were 
producing by base-catalyzed Pfitzinger reaction of 5- and 7-methylisatins with methyl 
and ethyl phenyl ketones, in the presence of KOH in ethanol and water, generating 
the desired 2-phenylquinoline-4-carboxylic acids, with methyl groups varied at the 3-, 















     The Niemantowski and Borsche variations, substituting o-aminobenzyl carboxylic 
acids and o-aminoarylimines for o-aminobenzaldehydes, respectively, have been 
applied or reexamined considerably less often than the Friedländer and Pfitzinger 
reactions.  One very recent example of the Borsche modification was used to attach 
quinoline precursors to TentaGel-Br resin, and generate the desired 
dimethoxyquinolines in a parallel solid-phase support sequence.  In this example, the 
desired resin-supported Borsche azomethine was generated by treatment of the free 
resin with 3,4-dimethoxy-6-nitrobenzaldehyde in refluxing ethanol.  After reduction 
of the nitro group with sodium sulfide, typical Borsche conditions—refluxing ethanol 
in the presence of piperidine—was used to condense a variety of ketones with the 




alkylquinolines in excellent yield (Scheme 33).  The expected facile purification, by 



























     Another Friedländer-like method that has been used in several recent studies is the 
Baylis-Hillman methodology.  Using !,"-unsaturated ketones, condensing them with 
o-nitrobenzaldehydes in a Baylis-Hillman fashion, results in the addition of a two-
carbon unit, which is still susceptible to attack by nitrogen nucleophiles to complete 
the quinoline system.  In Familioni’s work (Scheme 34), o-nitrobenzaldehyde was 
treated with methyl vinyl ketone, methyl acrylate and ethyl acrylate in the presence of 
1,4-diazabicyclo[2.2.2]octane (DABCO) to afford the desired Baylis-Hillman 
adducts.  After reduction of the nitro group with H2 and 10% Pd/C, the anticipated 





















     This Baylis-Hillman approach was also used in two publications out of the Jae 
Nyoung Kim group from Chonnam National University.  In the first publication, 
reaction of their Baylis-Hillman acetates with tosylamide in the presense of potassium 
carbonate afforded the desired quinolines in 55% yield.  This one-pot reaction occurs 
through sequential reaction of the Baylis-Hillman acetate with the tosylamide, 
followed by nucleophilic aromatic substitution with the ortho-substituted halogen to 
form a tosylamidodihydroquinoline, followed by elimination of the p-toluenesulfinic 
acid to form the desired quinoline.  The final elimination is not as facile as desired, 
and some dihydroquinoline (2-10%) was isolated.92 In Kim’s second publication, 
their Baylis-Hillman acetate is directly cyclized with the o-nitro group using catalytic 
triflic acid (Scheme 35).  Two mechanisms are proposed to account for the observed 
production of 3-acyl-4-hydroxyquinoline-N-oxides, with the authors favoring the N-

























     Besides the aforementioned Skraup and Friedländer methods, the use of 
organometallic reagents has played a dominant role in quinoline syntheses, in a 
manner similar to the rest of synthetic organic chemistry.  These organometallic 
reactions include amine exchange reactions, nitro group reductions catalyzed by a 
variety of metals, metathesis reactions, and coupling reactions.   
     The earliest noted example was by Tsuji in 1987.  This work demonstrated that 
substituted anilines react with 1,3-propanediol, in refluxing diglyme, in the presence 
of a catalytic amount of ruthenium trichloride hydrate (RuCl3
.nH20)-tributylphosphine 
(PBu3) to give quinolines in modest yields (37-59%).  The proposed mechanism of 
such a transformation included N-alkylation of both hydroxyl groups of the diol, 
forming a propylenediamine intermediate, which underwent ruthenium-catalyzed 
dehydrogenation to the imine, and after electrophilic substitution from the second 
amine, formed the dihydroquinoline.  This dihydroquinoline was dehydrogenated 









































     A number of ruthenium-catalyzed quinoline syntheses has been reported by the 
group led by Chan Sik Cho at Kyungpook National University.  Their first two 
reports utilized anilines and triallylamines and trialkylamines in a cascade amine 
exchange reaction, similar to Tsuji’s observations.  The amine transferred, 
dehydrogenated to form ruthenium-iminium complexes, and finally cyclized to form 
2,3-alkyl-quinolines in good yield.96,97 In their more recent examples, a consecutive 
reduction of nitroarenes and cyclization with amino alcohols, catalyzed by ruthenium, 
formed a variety of substituted quinolines in excellent yield (Scheme 37).  Unlike the 
Tsuji work, their process required a catalytic amount of SnCl2, for unknown reasons.   
The SnCl2 appeared to be necessary for both the reduction and cyclization steps.









     The reduction of a nitro group, followed by cyclization, is a methodology used by 
several other groups besides Cho.  In Zhang’s group, both titanium(IV) chloride and 
samarium(II) iodide have been used in such a manner.  In the case of titanium, a 
combination of TiCl4/Sm was used to selectively reduce aromatic nitro groups to 
anilines in the presence of a vinyl cyano group, which induced cyclization with the 
cyano group to form 2-aminoquinolines in excellent yield (Scheme 38).100 In two 
subsequent reports, SmI2 was used to reduce aryl nitro groups to anilines, and 
subsequently induce cyclization to form quinolines.  In the first such example, SmI2 
was used in manner analogous to the titanium work, selectively reducing the nitro 




aminoquinolines.101 In the second example, 2-nitro-1,3-diphenyl-2-propen-1-ones 














     Other authors have reported nitro group reductions, followed by condensation with 
an ortho-functionalized aldehyde chain to produce quinolines.  In the work by Boix, 
2-nitrocinnamaldehyde was reduced by Zn/H2O in a high temperature/pressure 
reactor, and cyclization afforded quinoline in high yield.  Subsequent reduction of 
quinoline was minimal, and only a small fraction of tetrahydroquinoline was isolated.  
In contrast, the analogous ketones and carboxylic acids formed significantly more 
over-reduced tetrahydroquinolines, limiting the use of this technique.103 In the work 
by Banik, the nitro group reduction was mediated by indium in the presence of 
ammonium chloride, producing quinolines in excellent yield (~90%).104 In 1996, 
Cenini used ruthenium-catalyzed carbonylation of 2-nitrochalcones to attempt to form 
indoles, however a significant by-product of such conditions was the reduction of the 
nitro group to an aniline, which could similarly condense with the !,"-unsaturated 
ketone to produce 2-arylquinolines in good yield (46-85%) (Scheme 39).105 In work 
by Banwell in 2004, palladium-catalyzed Ullman cross-coupling of "-halo-enals with 
bromonitrobenzenes formed o-nitrocinnamaldehyde, which could be reductively 























     Ring-closing metathesis (RCM) has also been used as an organometallic route to 
quinolines.  In 2001 and 2004, Arisawa reported the synthesis of quinolines starting 
from N-allyl-N-protected-o-aminostyrenes, using second and fourth generation 
Grubbs’ catalysts to induce the RCM (Scheme 40).  In each case, the yields were 
outstanding, and the N-protecting groups were removed by air oxidation following 
purification.107,108 In 2005, the same group applied this RCM technique to the total 
synthesis of the tetrahydroquinoline (+)-(S)-angustureine.  This unnatural enantiomer 
was used to determine the absolute stereochemistry of this antimalarial and anti-
























     Other more isolated examples of organometallic reactions in quinoline formation 
have been noted.  In Amii’s work, Rh(I) complexes were found to catalyze the 




trifluoromethylated quinolines in good yields.110 In 2002, Jiang reported a zinc(II)-
mediated alkynylation-cyclization of o-trifluoroacetyl anilines to form 4-
trifluoromethyl-quinolines.111 Diallylanilines have been converted to 
dialkylquinolines by Co2(CO)8 by Jacob and Jones.
112,113 Also, ","-difluoro-o-
isocyanostyrenes have been demonstrated to react with organomagnesiums or 
organolithiums to generate an sp2 carbanion on the isocyano carbon, which can 
cyclize via substitution of one of the fluorides, leading to 3-fluoroquinolines.  This 
cyclization is possible due to the unique reactivity of gem-difluoroalkenes toward 
nucleophilic substitution via an addition-elimination process.114 A similar, but 
reverse-polarity transformation was done with lithiated o-isocyano-"-
methoxystyrenes where the isocyano group was attacked by the carbon nucleophile to 
form 3-methoxyquinolines.115,116     
 
CYCLOADDITIONS 
     Electrocyclic reactions have also played a significant role in the synthesis of 
quinolines.  The most noteworthy examples used the Diels-Alder reaction.   In the 
1994 work by Nicolaides, two isomeric ethyl [10-(methoxyimino)phenanthren-9-
ylidene]acetates were reacted with two dienophiles, 1,4-benzoquinone and 
1,4-napthoquinone to form tetrahydroacridine carboxylates in excellent yield 
(Scheme 41).  The same diene was also reacted with maleic anhydride to form a 




























     In 2002, Yadav reported the InCl3-catalyzed aza-Diels-Alder reaction of 3,4-
dihydro-2H-pyran (DHP) with aryl amines to form tetrahydropyranoquinolines in 
excellent yield (70-90%).  The in situ generated aryl imines react selectively to form 
predominately endo products, and the reaction is generally mild and fast (~4h).118   
     Purportedly the first example of asymmetric tetrahydroquinoline synthesis by the 
inverse electron demand Diels-Alder reaction was reported by Sundararajan et al. in 
2001.  In this work, benzylidene aniline was reacted with various dienophiles in the 
presence of a chiral titanium catalyst to produce moderate yields, but poor to modest 
diastereo-and enantioselectivities.  Dihydropyrans, dihydrofurans, cyclopentadienes 
and ethyl vinyl ethers were used as dienophiles, with similar results.119 The work of 
Koyama and coworkers applied the Diels-Alder reaction to 1,2,3-benzotriazine with a 
variety of pyrrolidene enamine dienophiles.  This last Diels-Alder example, although 
limited by modest yields, produced various 2,3-alkyl, carbocyclic-, and aryl- 
substituted, fully unsaturated quinolines based on the elimination of diatomic 


























     Other examples of cycloaddition reactions forming quinolines include Parker’s 
thermal 6$-electrocyclic annulation of vinyl quinone mono- and diimides.  In these 
reactions, 6-amino and 6-hydroxyl-2-quinoline carboxylates are formed in good 
yields from readily-formed starting materials (Scheme 43).  This sequence is 
particularly attractive in forming the 6-oxygenatedquinolines, since they appear in 




















(TBAF or K2CO3)  
 
     Sangu’s approach produced 2-arylquinolines by electrocyclization of alkynyl aryl 
imines catalyzed by 20 mol% W(CO)5(THF) in good yields, although the yield was 




NMO (Scheme 44).  This procedure was relatively tolerant of both electron-
withdrawing and electron-donating groups on the aniline ring, as well as ortho- and 
meta-substituents, and, therefore, would be useful in generating a variety of 
substituted 2-arylquinolines.122   
 
Scheme 44 






     In the last cycloaddition example, Shimizu reported on the [4+2] cycloaddition of 
N-aryl substituted ketenimines with enol ethers.  The reaction used several 
dihydrofurans to attack the sp carbon of the ketenimine group, which allowed the 
[4+2] cycloaddition to occur, leaving a furo-dihydroquinoline, which quickly 






























     The last category of quinoline syntheses to report is that of multicomponent 
condensations.  In 1995, Westerwelle reported the domino reaction of N-methyl 
anilinium perchlorate salts with 2 eq of a variety of alkyl aldehydes, which produced 
2,3-alkyl-N-methyl quinolium perchlorates.  The yield of this initially undesired 
product was optimized by the authors as much as possible by varying solvents, 
temperatures, and Lewis acids, with minimal improvement to the low to moderate 
yields.124 In 2002, Syeda Huma reported the three-component reaction of aryl 
aldehydes, p-methoxyaniline, and terminal alkynes to produce 2-aryl-4-
hydroxylalkyl-quinolines in modest yield (Scheme 46).  This Cu(I)-catalyzed 
multicomponent reaction is expected to produce a combinatorial library of quinolines 
















     CONCLUSION 
     A wide variety of approaches have been developed for the synthesis of the 
quinoline ring structure, including Skraup and Skraup-like techniques, Friedländer 
and Friedländer-like techniques, organometallic techniques, cycloadditions, and 




disadvantages.  Some require unstable or synthetically challenging starting materials; 
others necessitate harsh reaction conditions.  However none of those methods were 








     Meyer and Schuster first reported the acid-catalyzed rearrangement of propargyl 
alcohols to !,"-unsaturated ketones in 1922126 (Scheme 47).  They catalyzed their 
reactions with a variety of acidic systems, including acetic acid/sulfuric acid 












     From that time until 1971 when Swaminathan and Narayanan wrote their 
review,127 a myriad of acid-catalyzed examples were reported, as well as a few base-
catalyzed examples for both the Meyer-Schuster (MS) rearrangement as well as the 
similar Rupe rearrangement (Scheme 48).  That review also summarized the 
substrates capable of such rearrangements:  (1) Rupe rearrangements were favored 
when an abstractable !-proton was available, while the MS rearrangement occurred 
when no such proton existed, and (2) the propensity for these types of rearrangement 
to occur followed a general carbocation stability pattern:  primary !-acetylenic 
alcohols never rearranged, secondary alcohols did so only with additional stabilizing 
















Meyer-Schuster Rearrangement -- (1,3-propargylic shift) Rupe Rearrangement -- (dehydration-hydration)
 
     The harsh acidic conditions used in those early reports of the Meyer-Schuster 
rearrangement led to a variety of by-products, mostly undesired, including competing 
rearrangements, methyl group migrations, and deoxygenations.127 Since the 1970s, 
several transition metal catalytic systems have been identified to facilitate the MS 
rearrangement, yet none that are both mild and universally applicable.  Early 
examples of transition metal catalysts employed titanium (IV) oxides,128 vanadium 
(V) oxides,129-133 rhenium (VII) oxides134 and molybdenum (IV) oxides.135 These 
systems were only marginally less harsh, often requiring elevated temperatures and 
organic acids. 
     More recently developed catalysts have achieved the MS rearrangement under 
mild conditions, but each with their own drawbacks.  In 2002, Suzuki reported the 
conversion of secondary propargyl alcohols to enals utilizing an aqueous 
cyclopentadienyl-ruthenium complex at 100 °C (Scheme 49).  This system was 
particularly high-yielding for the examples given, yet is limited to secondary alcohols 














     Cadierno also utilized a ruthenium complex to catalyze both the MS and Rupe 
rearrangements.  His (%3-allyl)-ruthenium(II) complex was capable of isomerizing 
both secondary and tertiary propargyl alcohols, however was limited to terminal 
alkynes in a manner similar to Suzuki’s work due to the vinylidene-ruthenium 
mechanistic pathway of the reaction.137,138   
     Examples of metal-catalyzed MS rearrangements of internal alkynes have also 
been recently reported.  Sugawara achieved silver(I)-catalyzed, carbon dioxide-
mediated MS rearrangements of tertiary propargyl alcohols in excellent yield.139  
Imagawa also reported the rearrangement of primary propargyl acetates to enones 
using Hg(OTf)2 in aqueous acetonitrile.
140 However, the most interesting recent 
reports of metal-catalyzed MS rearrangement have come out of the Dudley research 
group at Florida State University.  Using gold catalysts (AuCl3 and AuCl-AgSbF6), 
Dudley achieved MS rearrangement of both tertiary and secondary propargyl alcohols 









R = alkyl, alkenyl, phenyl  
 
MECHANISTIC STUDIES 
     Early investigations of the MS rearrangement concluded that elimination of the 
protonated hydroxyl group resulted in an alkynyl cation (20), which would be in 




reportedly stable enough, with a half-life of 45 min at 25 °C in conc. H2SO4, to be 







































    In 1977, Edens published kinetic studies of the MS rearrangement.144 Using a 
combination of Hammett analysis of substituent effects and solvent isotope effects, 
Edens concluded from the substituent effects data that the transition state has definite 
cationic character, and has substantial charge delocalized from the reaction center to 
the rearrangement terminus.  Also, from the inverse !-secondary isotope effect 
observed, Edens concluded that the rate-limiting step involves a partial 
rehybridization (sp & sp2), implying covalent attachment at the rearrangement 
terminus.  However, Edens’ data could not distinguish between an intramolecular 
shift of the oxygen versus a bimolecular process involving nucleophilic attack by 




















Figure 5.  Eden’s Proposed Transition State Models 
 
     Computational studies have also been reported with regard to the mechanism of 
the MS rearrangement.145-147 The most recent report of density functional theory 
calculations by Yamabe concludes that (1) the MS rearrangement is indeed a 
bimolecular process, and (2) transition state geometries are carbonium-ion like, with 
the C-O bond length of the departing oxygen at 2.71Å, and that of the attacking 




















Figure 6.  Yamabe Transition State Model for MS rearrangement of 1,1-
diphenylprop-2-yn-1-ol. 
 
     This latter result was contrary to their calculations for the Rupe rearrangement, 
which showed almost identical bond lengths for the departing and attacking oxygens.  
Yamabe attributed this difference to the carbocationic charge stabilization by the two 




so than the Rupe) requires electron-donating groups to facilitate the isomerization 
from propargyl alcohol to allenol.  Yamabe also highlighted the difference in 
activation energy calculated for the rearrangement of 1,1-dimethylprop-2-yn-1-ol 
('E‡ = 29.92 kcal/mol) and 1,1-diphenylprop-2-yn-1-ol, ('E‡ = 13.42 kcal/mol) as 
further evidence of the role of the phenyl groups in stabilizing the carbocationic 
nature of the transition state. 
 
APPLICATIONS 
     Although heavily studied both methodologically and mechanistically, application 
of the MS rearrangement is less commonly identified in the literature.  An early 
example was reported by Pelletier in his synthesis of three monoterpene pheromones 
(22, 23, and 24, Scheme 52) of the male boll weevil Anthonomus grandis Boheman in 
1976.  The rearrangement of the acetate of 1-ethynyl-3,3-dimethylcyclohexanol was 
not stereoselective, resulting in a 47:53 mixture of the two desired aldehydes in high 
(88-90%) yield.  Those aldehydes could be further reduced to produce a mixture of 
























     Amos Smith also utilized tris(triphenylsiloxy) vanadate to catalyze a MS 
rearrangement enroute to his total synthesis of three members of the thujopsene class 











Lastly, two more recent examples of the application of the MS rearrangement in 
natural product synthesis include the work by Crich on the AB-ring system of taxol150 
and the synthesis of novel histamine H3-receptor antagonists by Stark et al.
151  
     Despite the wealth of studies on the various types of acid and transition metal 
catalysts capable of facilitating this rearrangement, and several theoretical studies on 
its precise mechanism, application of the Meyer-Schuster rearrangement in synthesis 
has been relative rare.  However, its potential role in the quinoline heteroannulation to 







     Streptonigrin (1) is an aminoquinone antibiotic with significant antitumor, 
antiviral and antimicrobial activity.   Since its isolation by Rao and Cullen from 
Streptomyces flocculus in 1959, streptonigrin has been thoroughly studied, both 
chemically and medicinally (vide infra).  Despite its effectiveness as a chemotherapy 
agent for a variety of cancers (breast, lung, head, neck, lymphoma and melanoma),152 
streptonigrin displayed deleterious side effects, including bone marrow depression, 
and clinical trials were abandoned in 1977.  Since that time, a body of work has been 
undertaken to identify the mechanisms of both its anti-neoplastic activity as well as 
its clastogenic activity.  The primary goal of these studies was to identify 
streptonigrin’s active pharmacophore, allowing the rational design of an analogue that 
would modulate the clastogenic activity while maintaining the anti-neoplastic effects.  
To date, streptonigrin’s fully-functionalized tetracyclic structure has successfully 
synthesized by only three research groups,153-155 although many other efforts have 
been reported toward segments of the streptonigrin structure.  Those lengthy total 
syntheses, however elegant, would not be commercially viable for the production of 
streptonigrin, or any newly identified, efficacious analogue.  In that regard, a new 






MODE OF ACTION / PHARMACEUTICAL VALUE 
     Streptonigrin has long been known to have an array of cytotoxic and genotoxic 
effects.  Its cytotoxicity has been linked to depletion of NADPH/NADH, the 
uncoupling of oxidative phosphorylation, leading to observable depletion of cellular 
ATP, as well as severe DNA degradation.  The numerous investigations on the impact 
of streptonigrin on DNA have been thoroughly reviewed in a recent report by Bolzán 
and Bianchi.152  That report summarized streptonigrin’s unique activity both as a 
radiomimetic compound, damaging chromosomes in an S-independent manner, as 
well as causing G1-phase chromatid-type aberrations and sister-chromatid exchanges 
typical of S-dependent agents.  Streptonigrin binds irreversibly to minor groove of 
DNA, and its clastogenic effects have been shown to be persistent long after 
exposure.   
     Streptonigrin has been shown in vitro to be reduced by a one or two-electron 
process, producing semiquinone radicals or hydroquinone, respectively.  Either 
species is capable, through Fenton-type reactions to produce superoxide radicals and 
hydroxyl radicals capable of damaging DNA.  Once bound to DNA, this cyclical 
process can cause chromosomal aberrations in nanomolar concentrations, and such 
damage can persist through multiple cell cycles.156  The role of those active oxygen 
species was indirectly demonstrated by the addition of liposome-encapsulated 
antioxidant enzymes superoxide dismutase and catalase, as well as the hydroxyl 
radical scavenger mannitol, to Chinese Hamster ovary (CHO) cells, which 




     Similarly, the role of metal ions in streptonigrin-mediated DNA damage has been 
evidenced by the addition of metal chelating compounds such as desferrioxamine, 
2,2-dipyridyl and 1,10-phenanthroline to streptonigrin-exposed cell lines.  In each 
case, the chelators significantly inhibited the induction of chromosomal 
aberrations.152   
     One particularly interesting study by Harding’s group from the University of 
Sydney highlights the continued interest in identifying the role of d-block metal ions 
in the redox chemistry of streptonigrin-mediated DNA damage.157  The redox 
potentials of the quinone in streptonigrin were studied by cyclic voltammetry (CV) in 
the presence of varied concentrations of metals (Cd(II), Fe(II), Zn(II), Co(II), Mn(II) 
and Ni(II)).  Harding observed a reversible single-electron reduction in the presence 
of metal ions (Scheme 54), which occurred at a more positive potential (more easily 
































     The same CV experiments were also performed on two AB-ring segments of 
streptonigrin (with and without the 7-amino group, no CD ring component).  The 
observed quinone redox potentials were also positively shifted in the presence of the 
metal ions, however the magnitude of that shift was significantly more than for 




coordination to the quinone oxygen would be greater, impacting the redox potentials.  
However, streptonigrin’s metal coordination would be influenced by the C-ring 
pyridyl nitrogen as well as the carboxylate, limiting the impact on the quinone 
system.   
     This hypothesis agreed with past studies attempting to identify the active 
pharmacophore of streptonigrin.158  Boger synthesized a broad spectrum of AB-ring 
segments, CD-ring segments, and ABC-ring analogues, systematically excluding 
components of the proposed streptonigrin-metal complex.  Boger tested these 
analogues for antimicrobial and cytotoxicity, and found that: 
     (1) the fully functionalized CD-ring alone was biologically inactive;  
     (2) the AB-ring 6-methoxy group was relatively unimportant; 
     (3) the C-ring pyridyl nitrogen was extremely important (it’s carbocyclic analogue 
was significantly less active;  
     (4) the role of the C-ring free carboxylate was ambiguous, fully functionalized 
streptonigrin was much more active than its methyl ester derivative, but smaller 
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Figure 7.  Boger’s Streptonigrin Analogues to Determine the Active Pharmacophore 
      
Previous AB-Ring Syntheses 
     The past efforts toward the synthesis of the quinoline-5,8-quinone AB-ring of 
streptonigrin have been focused on utilizing the known quinoline syntheses discussed 
earlier.  The earliest example was developed by Kametani, using a classical Skraup 
reaction of diamino-trimethoxybenzene 25 (Scheme 55),4 which after oxidation, 






















25 26  
 
     A similar Skraup synthesis route was taken by Cheng159 to form 6-
methoxyquinone 27.  This quinone was further functionalized to introduce the 7-




azide, and reduction to form the 7-amino-6-methoxyquinoline-5,8-quinone 28 
(Scheme 56).  This strategy was later successfully used in both Weinreb and Kende’s 























27 28  
 
 
     In 1979, Rao reported the synthesis of ABC-ring segments of streptonigrin via a 
two-step Friedländer approach,160 condensing acetylpyridine 30 with 
nitrobenzaldehyde 29 to form the nitrochalcone 31.  Reductive cyclization of 
chalcone 31 with sodium dithionite produced the desire quinoline in excellent yield.  
Subsequent oxidation to the quinolinequinone was complicated by the partial 
formation of a dimethyl acetal byproduct, which after separation could be cleaved 
with acid to produce the quinone in a combined yield of 55%.  Rao also utilized the 














































In that same report, Rao also made an interesting hypothesis, proposing that the 2,4,6-
trinitro-3,5-dimethoxytoluene 32 would make a simple, yet ideal A-ring precursor for 
the same two-step Friedländer approach.  Despite its potential as an explosive, he 
synthesized 32 on a relatively large scale (13g), yet reported he could find no 
appropriate oxidation conditions to transform the toluene methyl group into an 
aldehyde (Scheme 58).  Oxidation of compounds similar to 32 would later be 






















THE WEINREB SYNTHESIS 
 
      Weinreb utilized many interesting transformations to complete the first total 
synthesis of streptonigrin,153 including an imino Diels-Alder reaction to form the C-
ring pyridine.  However, this discussion will focus on his specific approach toward 
the AB-ring system.  Preliminary efforts toward the AB-ring by Weinreb identified a 
modified Friedländer approach, utilizing a Wadsworth-Emmons-Horner condensation 
of "-ketophosphonate 34 with a nitrobenzaldehyde 33 to successfully form the 
desired nitrochalcone in 80% yield.  This nitrochalcone was reduced with sodium 
dithionite, cyclizing to form the pyridylquinoline 35 in 60% yield (Scheme 59).  This 
sequence was quite effective, however four steps were required to build the "-
ketophosphonate 34 from his last CD-ring intermediate, with a 41% overall yield.  In 
addition, nitrobenzaldehyde 33 was merely referenced as a known compound, but the 
effort required to produce it was not included.  Overall, Weinreb’s work to produce 
synthetic streptonigrin, although elegant and certainly timely, required 32 linear steps 














































THE KENDE SYNTHESIS 
     In a manner similar to that of Weinreb, Kende chose to construct streptonigrin 
from the D-ring “north”.  However, to assemble the AB-ring, Kende chose a Borsche 
reaction to form the heterocyclic B-ring.  He arrived at a 2-chloropyridine CD-ring 
intermediate which could be modified in 2 steps (70% yield) to his Borsche adduct 
2-acetylpyridine intermediate 37.  Kende’s A-ring precursor, iminoaniline 36, was 
prepared in three steps (60%) from the known compound 5-hydroxy-2-
nitrobenzaldehyde.  The commercial availability of such aldehyde at that time is 
unknown.  The subsequent Borsche reaction was quite fruitful, producing the 
tetracyclic product in  90-96% yield.  Kende’s total synthesis of streptonigrin required 































RECENT AB RING SYNTHESES 
 
     More recent efforts at heteroannulation of the AB-ring system of streptonigrin 
have utilized Heck coupling approaches to form the 3-carbon segment required for 
assembling the B-ring.  In an on-going effort by Quéguiner, a series of 2-quinolones 
were produced, one with the proper A-ring functionality, by a sequence of ortho-
directed metalation, iodination, Heck coupling with methyl acrylate and acid-
catalyzed cyclization (Scheme 61).161  This process, however high yielding, results in 
a quinolone that is converted in 2 steps to a 2-quinolyltrimethylstannane, for 
subsequent Stille coupling to a 2-pyridyl triflate CD-ring analogue.  No 
pharmaceutical-friendly palladium-catalyzed aryl-aryl coupling reactions have 


































     A recent report by Holzapfel and Dwyer also utilizes a Heck coupling to form the 
AB-ring system (Scheme 62).162  Dinitration of dimethoxyphenol 38 with nitronium 
tetrafluoroborate formed the dinitrophenol 39 in good yield (no regioselectivity issues 
were addressed).  Treatment with triflic anhydride generated the aryl triflate needed 
for Heck coupling.  Reductive cyclization afforded 2-hydroxyquinoline in excellent 
yield.  In a manner similar to Quéguiner, Holzapfel planned to convert 40 to 2-
quinolyl triflates and utilized Stille coupling with 2-pyridyltrimethylstannanes to form 




































     The aforementioned efforts to form the AB-ring system, although successful in 
their own right, were not sufficient for our planned synthesis of streptonigrin.  
Whether hampered by long lead-in steps, undesired organostannane coupling 
reagents, or omitted A-ring functionality that would be added post-cyclization, these 
precedents would not meet our goal of utilizing McElroy’s CD-ring pyridyl triflate 2 
(Figure 1) in a mild, yet efficient, manner.  A new quinoline synthesis was required 
that would couple to 2 using mild, non-toxic organometallic reagents, produce the 
AB-ring with minimal post-cyclization modifications, and do so in a convergent 
manner that would allow the greatest flexibility in producing analogues that may be 





Results and Discussion 
Tandem Reduction/Cyclization of o-Nitrophenyl Proparygl Alcohols 
AB RING MODEL SYSTEMS 
     In our on-going efforts to synthesize streptonigrin (1),2 (Scheme 64)1 McElroy 
developed an efficient route to the functionalized, protected CD pyridyl triflate 2.   
This convergent approach produced the highly functionalized C ring intermediate 
bromopyridine 41 in a 10-step sequence, and the requisite D-ring boronic acid 42 in 3 
steps.  Following successful Suzuki coupling of these arenes, the 2-methoxy group 
was converted to triflate in two steps, generating the CD-ring intermediate pyridyl 




































     McElroy also investigated routes to couple that intermediate to preassembled AB 
ring precursors (Scheme 64, Paths A & B), or an A ring precursor with a subsequent 




precedents for forming 2-(2’-pyridyl)quinolines via organometallic cross-coupling 



































































     McElroy investigated a model system for pathway A.  The synthesis of the 
quinoline siloxane 43 (Scheme 65) from 2-bromoquinoline, by either hydrosilylation 




unsuccessful, and gave only low yields of the desired siloxane.  The analogous 
quinoline stannane 44 was generated in modest yield, but Stille coupling attempts 
with 2-pyridyl triflate yielded none of the desired biaryl product.  In addition, both 
siloxane 43 and stannane 44 were unstable, and protodemetallated on standing 
leaving quinoline.1  
Scheme 65 
N Si(OEt)3 N N SnBu3
N
43 44  
 
     The cross coupling of aryl siloxanes  and allylic benzoates required for Path C was 
studied in a model system, and produced moderate yields of the desired olefin 45 
(Scheme 66).  However, intramolecular amination attempts produced 2-












     Since McElroy’s work exhausted the siloxane aryl-aryl and aryl-allyl coupling 
possibilities, we needed to develop a new retrosynthetic path, preferably one with a 
mild cross-coupling step that took full advantage of the readily available CD 




the heterocyclic B ring subsequently.  Success in that regard would require a new 
quinoline-forming technique.  
     The development of a new quinoline synthesis (Scheme 67) to meet our needs 
started with the well-precedented transformation of nitrochalcones 46 to quinoline by 













     In one such example, Banwell and coworkers106 reduced the nitro groups of (Z)-"-
nitroaryl-enals 47 to form a series of 2,3-substituted quinolines 48 in good to 
excellent yields (Scheme 68).  Where our synthetic plan diverged was in the 













47 48  
 
     Our first plan to produce the pyridyl nitrochalcone 46 centered around a proposed 
carbonylative Heck reaction (Scheme 69).  Oxidative addition of palladium into the 
pyridyl-triflate bond, followed by carbon monoxide insertion, alkene insertion, and "-












NO2   
 
     However, atmospheric pressure carbonylative Heck reactions normally proceed 
with alkene migration first, followed by insertion of the carbon monoxide,174 forming 
an acyl palladium species.   High pressure carbonylative Heck reactions have been 
used to generate quinolones 49 (Scheme 70).175  Attempts by Torii and coworkers to 





















     Analogous processes using terminal alkynes have been thoroughly studied by 
Larock,176,177 demonstrating that high pressures are required to force carbon 
monoxide insertion to occur before the alkyne insertion.  Under low-pressure 


























     In order to develop a novel, practical approach, circumventing the need for high-
pressure, we envisioned a carbonylation using a solid isocyanide 50 as the carbon 
monoxide synthon (Scheme 72).178 Isocyanides are isoelectronic with carbon 
monoxide, and are known to insert into palladium-carbon (-bonds in a similar 
manner,179-183 however we could find no synthetic application of such an insertion 




















     Several catalyst/base/additive combinations were surveyed as potential conditions 
for the model transformation with 1-octene:  using Pd/C or Pd(PPh3)4 as catalysts, 
with either potassium carbonate or triethylamine bases, with and without lithium 
chloride additives.  Unfortunately, no pyridyl enone 52 was observed under any of 
these conditions (Scheme 73).  Removal of the isocyanide 50, and simply attempting 
the Heck reaction alone on 2-pyridyl triflate 51 with 1-octene produced no cross-
coupled product.  The only coupling observed under these conditions was 
homocoupling, producing 2,2’-bipyridine 53.  Accordingly, this approach to the 

















     Next we chose to examine the potential of a Sonogashira coupling using our 
2-pyridyl triflate CD ring intermediate.  This reaction was modeled using 
commercially available 2-pyridyl triflate 51 and TIPS-acetylene (Scheme 74).  Under 
standard Sonogashira conditions, using 2 mol% tetrakistriphenylphosphine palladium, 
copper iodide and excess triethylamine, the reaction produced TIPS-pyridyl acetylene 










     This result led us to devise a new route to our desired pyridylnitrochalcone 
(Scheme 75).  Starting from readily available o-nitrobenzaldehyde 60, adding an 
acetylene unit to make the secondary propargyl alcohol 59.  This alcohol could be 
coupled using Sonogashira conditions to the CD ring pyridyl triflate.  The resulting 
pyridyl propargyl alcohol 58 could be transformed into the required o-aminochalcone 




rearrangement could be performed on the o-nitrophenyl propargyl alcohol, generating 




























     Testing this approach, ethynylmagnesium bromide reacted with 
o-nitrobenzaldehyde 60 to form the terminal secondary propargyl alcohol 59 (96%).  
Anticipating the hydroxyl group would require protection for the upcoming 





































     With a variety of propargyl alcohols in hand, we investigated the Sonogashira 
reaction of pyridyl triflate 51.  Although our previous assumption appeared to be 
correct, and the unprotected propargyl alcohol 59 did not couple, the TIPS-protected 
61 coupled well (Scheme 77).  Stirred at room temperature, with 2 mol% 
tetrakistriphenylphosphne palladium, copper iodide and triethylamine, the desired 






























     We anticipated that reduction of the nitro group would increase the electron 
density of the phenyl ring, hopefully facilitating the Meyer-Schuster rearrangement.  
Therefore, pyridyl propargyl alcohol 65 was subjected to nitroarene reduction 
conditions184 (Scheme 78).  Iron metal stirred in ethanol with aqueous HCl and 
aqueous ammonium chloride produced none of the intended aniline 66.  Instead, a 
complex reaction mixture was obtained, the products of which would be identified 
later.  However, when terminal alkyne 61 was subjected to the same reducing 
conditions, we observed a dramatically different, and immediately clear result.  
Reduction of 61 produced a mixture of the expected aniline 67, in 33% yield, and 























     Although the pyridyl-substituted example did not yield quinoline under reducing 
conditions, the fortuitous direct conversion of the o-nitrophenyl propargyl alcohols to 
quinoline in one pot deserved further examination.   A thorough literature search 




HIV-1 non-nucleoside reverse transciptase inhibitor efavirenz 69 (brand name 
SUSTIVA®), Choudhury and coworkers observed that many of their PMB 
deprotection schemes for tertiary propargyl alcohol 70 led to substantial, irreversible 
























     We were intrigued by Choudhury’s observation—although an undesired by-
product in DuPont’s synthesis—of the mild conversion of o-anilino-propargyl 
alcohols to quinolines, potentially through an acid-catalyzed Meyer-Schuster 
rearrangement.  This appeared to be an exploitable avenue to achieve our desired 
goal.  
     We developed a plan (Scheme 80) to study this transformation, starting from 
readily available o-nitrobenzaldehyde and 2’-nitroacetophenone.  The addition of a 




alcohols, and after reduction of the nitro group, we examined the quinoline-forming 















     Since Choudhury’s system involved tertiary propargyl alcohols, initial testing was 
done adding the lithium acetylides of 1-hexyne and phenylacetylene to 
o-nitroacetophenone, generating the propargyl alcohols 38 and 39, respectively 




188 With the exception of 
TiCl3/HCl, each of the reduction conditions produced 2-butyl-4-methylquinoline 40 
and 4-methyl-2-phenylquinoline 41 in excellent yields.  
Table 1.  Comparison of Reduction Conditions converting Tertiary Propargyl 










72  R = n-butyl
73  R = phenyl
74  R = n-butyl
75  R = phenyl  
entry R [H] H+ Yield %a 
1 n-butyl Fe HCl 95 
2 “ TiCl3 HCl < 40
b 
3 “ Zn AcOH 95 
4 “ SnCl2 HCl 91 
5 Phenyl Fe HCl 82 
 





     We propose this transformation occurs through a Meyer-Schuster 
rearrangement;189,190 the [1,3] propargylic shift of the hydroxyl group, followed by 
protonation of the resulting allenol, to produce an enone.  Although this mechanishm 
seems reasonable, repeated attempts to initiate this rearrangement on the secondary 
o-nitrophenyl propargyl alcohol 76 (Scheme 81) by both strongly acidic and basic 












     Based on this result, we believe this quinoline formation is only possible after 
reduction of the nitro group, due to the resonance-stabilization of the secondary 
alkynyl cation by the aniline (Scheme 82).  This mechanism is also supported by the 
relative ease of quinoline formation from tertiary propargyl alcohols compared to the 












































     In order to demonstrate the generality of this technique, a series of propargyl 
alcohols have been prepared, with subsequent reduction/cyclizations to quinolines 
(Table 2).   Entries 1 and 5 depict the n-butyl and phenyl secondary propargyl alcohol 
analogues of those examined in Table 1.  Both quinolines were formed in good yield, 
although not as high as their tertiary counterparts.  Entries 2, 3 and 4 examine the 
electronic effects of A ring substituents on the cyclization, and the success of those 
transformations demonstrates that any such substituent effect is minimal.  Entries 4 & 
6 do show a lower yield than other examples, however that diminished yield appears 
to result from difficulty isolating the sensitive product rather than inherent limitations 
with the reaction in question.  It is important to note the purification of these 
quinolines (84-89) was done by a combination of acid-base extractions and/or bulb-
to-bulb distillations since these low molecular weight quinolines were generally 
unstable to either silica, alumina or florisil chromatography.  In most cases the NMR 
spectra of crude product indicated the presence of the desired product in high purity; 
however, significant mass loss occurred during purification. 
     The pyridyl-substituted examples (entries 7 and 8) form the original impetus for 
this quinoline-forming reaction study, since the ultimate application of this quinoline 
heteroannulation with streptonigrin CD ring intermediate 2 requires formation of a 
2-pyridylquinoline.  Reductive cyclization of the pyridyl secondary propargyl alcohol 
82  generated quinolone 90, instead of the expected quinoline.   Further examination 





Table 2.  Further Secondary and Tertiary Propargyl Alcohol Examples 
entry   
Aldehyde/ 
Ketone 


























































































































































     In summary, the reduction-rearrangement of o-nitrophenyl propargyl alcohol 
derivatives provided 2-aryl-, 2-alkenyl and 2-alkylquinolines in good to excellent 
yield.  The methodology is tolerant of both electron-donating and electron-
withdrawing functionality on the A-ring and to substitution on the alkyne.  The 
combination of mild Sonogashira coupling of aryl triflates to terminal propargyl 
alcohols,  followed by direct reductive cyclization opens the door to the production of 
a variety of 2-arylquinolines with highly functionalized aryl groups, applicable to 
many quinoline-based natural product syntheses, including the synthesis of 
streptonigrin.     
 
FINAL ABC RING MODEL SYSTEMS--QUINOLONE FORMATION 
 
     The application of our quinoline heteroannulation methodology to the synthesis of 
streptonigrin requires the reductive cyclization to proceed as previously described 
with a pyridine unit attached at the terminal end of the propargyl alcohol.  Initial 
models of this system were described earlier, both in Scheme 77 and entry 7 in Table 
2.  In either case, the reductive cyclization produced no quinoline product 91, instead 
the 4-quinolone 90 was produced (Scheme 83).  In order to determine if our proposed 
route to streptonigrin is viable, two important issues would need to be resolved:  (1) 
precisely how this anomalous model system product is formed instead of the 
quinolines formed by other model system propargyl alcohols, and (2) whether or not a 













64  R = H









   
     The generation of 4-quinolone 90 can be rationalized by two distinctive pathways:  
(1) cyclization by a distinctly different mechanism, propagated by the electonic nature 
of the pyridyl substituent, or (2) reductive cyclization as previously described, 
followed by post-cyclization oxidation of 2-pyridylquinoline to quinolone.  One 
proposed mechanism for the former pathway (Scheme 84) involves a hydride shift, 
due to the electron-withdrawing nature of the pyridinium system at the terminal end 
of the alkyne.  The resulting allene, once protonated, would produce an enone system 
capable of ring closure with the aniline A ring function, producing a dihydroquinoline 
92, which would be either air oxidized or oxidized by the iron salts already present in 








































    The occurrence of this mechanism could be tested by one of two deuterium 
labeling studies.  Initally, we envisioned producing 1-deuteroaldehydes of our o-
nitrobenzaldehyde, and following the previous sequence of propargyl alcohol 
production to generate deuterated propargyl alcohol 93.  If, in fact, a hydride (or 


















93 94  
 
     However, a more expeditious route was taken where our currently available 
propargyl alcohol 64 was reductively cyclized in a deuterated solvent.  These 
conditions would allow us to track the proposed hydride shift as the protium shifts, 
generating the same quinolone we previously isolated.  If the Meyer-Schuster 
rearrangement occurred as previously described (Scheme 82), the protonation of the 
intermediate allenol would incorporate deuterium from the reaction solution, and the 




























     Analysis of the crude NMR from this reaction showed the complete disappearance 
of the 1H NMR singlet resonance at 6.62 ppm corresponding to the 3-position proton; 
the other 1H NMR resonances of the 4-quinolone 90 were present.  Isolation of this 
deuterated product was not done based on the potential for exchange of the deuterium 
with environmental protium.  Purification of these pyridylquinoline/quinolone 
reactions is normally carried out with an acid/base extraction, the conditions of which 








































     Another alternative rearrangement that would produce the same dihydroquinoline 
intermediate 92, and therefore the same quinolone product, is depicted in Scheme 87.  
Deprotonation would produce a cumulene intermediate, which after protonation 
would produce regioisomeric enone 95 relative to our previous Meyer-Schuster 
intermediates.  After reduction of the nitro group, cyclization could occur in a 
conjugate fashion, forming the same dihydroquinoline 92.  This dihydroquinoline is 
incapable of rearomatization via dehydration, and therefore persists until air oxidation 












































     This proposed mechanism would not be excluded by the aforementioned 
deuterium study.  This pathway would also be independent of the reduction of the 
nitro group, and therefore could be tested solely under acid-catalyzed conditions. 
Propargyl alcohol 96 (synthesis to be discussed in the following A Ring chapter) was 




was completely consumed, and only one product was produced (Scheme 88).  





















     Both 1H NMR and IR data confirm the structure of the pyridine and A rings are 
intact, including the aromatic resonances for the four pyridyl protons and the two A 
ring protons, as well as the methoxy groups.  The IR data confirms the existence of 
the nitro group, and shows a weak, broad stretch across the 3500-2500 cm-1 range 
which could be an O-H stretch.  The IR does not show any carbonyl stretch.  The 13C 
NMR spectrum also shows no carbonyl resonance, therefore excluding the proposed 
enone 97.  The remaining resonances on the 1H NMR spectrum appear at 5.57 and 
7.45 ppm, with corresponding 13C NMR resonances at 72.9 and 125.4 ppm, 
respectively.  These two resonances are also show weak coupling (J = 1 Hz).  One 
potential structure of 98 that would match these data would be the hydrated enone 99, 
















97 99  
 
     Another possible structure for this product would be enol 100, which is the result 
of acid-catalyzed hydration of the triple bond (Scheme 90).  This structure also 
matches the characterization data, and would be stable in the enol tautomeric form 
based on six-membered ring hydrogen bonding with the pyridine.  However, this enol 
would be expected to cyclize, after reduction of the nitro group, to form 


































     A third potential avenue for quinolone formation would involve quinoline 




followed by oxidation of the quinoline to quinolone.  This could occur through 
Fenton-type chemistry, with the resulting iron salts.  This was not observed in any 
non-pyridyl systems, but would be potentiated by the strong phenanthroline-like 












91 90  
 
     An oxidation of this nature could only be proven through production of 
2-pyridylquinoline 91 by other means, and then subjected to similar reductive 
cyclization conditions.  This avenue was not tested.  However, a recent study utilized 
Fe/HCl as the reducing agent in the Friedlander synthesis of 2-pyridylquinoline 91, 
with excellent yield and no reported post-cyclization oxidation.77 
     Despite the lack of definitive identification of 98, the fact that propargyl alcohol 
96 was capable of a non-Meyer-Schuster rearrangement under acidic conditions 
supports the contention that an alternative rearrangement is producing the observed 
quinolone.  Future efforts to apply this reductive cyclization to the synthesis of 






Application to the Total Synthesis of Streptonigrin--A Ring Synthesis 
 
     In order to exploit the aforementioned quinoline heteroannulation methodology to 
the synthesis of streptonigrin, an A ring intermediate aldehyde must be generated 
with the proper functionality to ultimately arrive at streptonigrin’s methoxy-
aminoquinone moiety.  The two aldehydes targeted in this work are 3,5-dimethoxy-2-
nitrobenzaldehyde (102), and 3,5-dimethoxy-2,4-dinitrobenzaldehyde (103) (Figure 
9).  Both aldehydes have a methoxy group in the correct position to direct oxidation 
to the p-quinone, as well as the methoxy group in the final 6-position of streptonigrin.  
Both aldehydes have the nitro group ortho to the aldehyde required for cyclization, 
however dinitroaldehyde 103 also has a nitro group positioned to be reduced 
concurrently with cyclization to generate streptonigrin’s 7-amino function.  This facet 








102  R = H






R = H, NH2
 
Figure 9.  Target Aldehydes for Streptonigrin AB-Ring System Synthesis 
 
     Mononitroaldehyde 102 is a known compound, that was previously generated via 




hands, the direct mononitration of the same commercially available 3,5-
dimethoxybenzaldehyde was best accomplished via a mild copper 
nitrate/Montmorillonite clay “claycop” procedure developed by Laszlo.193   This 
reaction was initially accomplished without the addition of nitric acid, and was 
complicated by a large amount of the gem-diacetate byproduct 104.  The formation of 
this byproduct was minimized by the addition of small amounts of nitric acid, and any 
remaining gem-diacetate was cleaved in an acidic workup step, leading to an 




































     Direct access to this targeted aldehyde in a high-yielding single step process 
allowed the further modeling of the quinoline methodology to form streptonigrin-like 
AB ring systems.  Addition of the lithium acetylide of 1-hexyne, as previously 
reported, formed the propargyl alcohol 105 in high yield, and the Fe/HCl reductive 



























102 105 106  
 
     Dimethoxyquinoline 106 was also subjected to initial screening of oxidation 
conditions to prepare the quinoline-5,8-dione moiety of streptonigrin.  However, 
Fremy’s salt oxidation was not sufficient to accomplish this transformation, leaving 
the starting quinoline unaffected.  Further studies with more robust oxidizing agents 













    The application of mononitroaldehyde 102 synthesis to streptonigrin, although 
expeditious, would ultimately leave the addition of the A ring 7-amino function to be 
accomplished at the end.  This addition has been well-precedented in the synthesis of 
many of the streptonigrinoid compounds, by the three-step sequence developed by 
Cheng159 (Scheme 56).  However, we sought to eliminate those post-cyclization 
manipulations by developing a synthesis of dinitrobenzaldehyde 103, and applying 




     Our efforts to synthesize dinitroaldehyde 103 took several paths, developed to 
control the regioselectivity of the dinitration, while maintaining the ability to 















































     Our initial success with claycop nitration led to the investigation of claycop’s 
potential to dinitrate orcinol derivatives.  In their report, Laszlo et al. described the 
addition of fuming nitric acid to claycop reactions to initiate dinitration.  However, 
none of the substrates used in that dinitration work contained oxidizable functional 
groups like an aldehyde.  In our hands, the addition of small amounts of concentrated 
nitric acid were necessary to limit the amount of gem-diacetate protection of our 




acid dictated by Laszlo’s report did not achieve dinitration (Scheme 96).  In fact, 















      The gem-diacetate byproduct 104 of our initial claycop mononitrations was also 
resubjected to claycop nitration conditions.  We anticipated that the steric bulk of the 
acetates might direct any second nitration to the para position, leading to the desired 
dinitrated regiochemistry.  However, only trace amounts of a dinitrated product 107 
were isolated, and the symmetry of that products NMR spectra indicated that the 
second nitro group was also added in the ortho position.  Accordingly, this avenue 


















     To control the regioselectivity of the second nitration, bromine was used as a 
blocking group.  Bromination of dimethoxybenzaldehyde with tetrabutylammonium 
tribromide194 yielded the known bromoaldehyde 108 in excellent yield.  Dinitration of 
that bromoaldehyde under claycop conditions resulted in only low yields of 
























     The only other direct dinitration reaction condition attempted on this aldehyde was 
using nitronium tetrafluoroborate.  This nitrating agent developed by Olah195 has been 
used on many occasions, reportedly due to its robust nitrating capability without the 
inherent oxidizing nature of mixed acid nitrations.  However, in our hands, nitration 
of dimethoxybenzaldehyde with 2.5 eq of nitronium tetrafluoroborate provided low 
yields of mononitrated product 102, and significant decomposition.  
     Since direct dinitration of a benzaldehyde intermediate could not be achieved, the 
next avenue investigated was dinitration of toluene compounds, leaving the 
subsequent benzylic oxidation of that toluene methyl group for a later step.  Claycop 
nitration of 3,5-dimethoxytoluene resulted in a poor yield of dinitrated product 111, 




















     The possibility of the two methoxy groups sterically controlling this nitration led 
us to examine the use of orcinol (3,5-dihydroxytoluene) as a starting material.  Since 
claycop nitrations require the use of acetic anhydride, which acylated the phenols, 




A two-step nitrosation/oxidation of resorcinol was utilized by McElroy, in one of his 
A ring precursors (Scheme 100).  These conditions were a modification of those 
originally reported in 1967 by Kametani in his synthesis of the explosive styphnic 
acid.  McElroy replaced the nitric acid oxidation of the nitroso groups with 
trifluoroacetic peracid oxidation to avoid the concomitant trinitration (Scheme 100).  
Application of this nitrosation/oxidation sequence to orcinol was also effective in 














































112 113  
 
     In a fashion similar to McElroy’s observations of dinitrosoresorcinol, the 
intermediate dinitroso compound 112 was relatively stable, however attempts to 
recrystallize this brown powder led to decomposition.  Therefore crude 112 was 
carried forward into the oxidation conditions, and the reported 49% yield for this 




this oxidation reaction could significantly improve the yield.  It was observed that 
excess hydrogen peroxide significantly diminished the yield of 113.  Careful titration 
of fresh hydrogen peroxide (nominally 30% as commercially available) before its use 
could prevent any further degradation of the product.  This type of optimization was 
postponed pending the validation of this route to our desired dinitroaldehyde.   
     The product of this nitrosation/oxidation sequence appeared to favor the desired 
regiochemistry, and X-ray analysis of 113 confirmed that regioselectivity (X-ray data 
in Appendix).  This observed regiochemistry seemed surprising at first, in light of our 
aforementioned direct nitration results; but after careful examination of the 
literature,196,197 the result was reasonably predictable (Figure 10).  After initial 
nitrosation at the same position ortho to the methyl group as we observed in 
mononitrations, the resulting nitrosophenol has a stable tautomeric form as a 
p-quinone-oxime 114.  This quinone-oxime would be preferentially nitrosated at the 
enolic position, leading to the desired 2,4-dinitrosoorcinol 112, in its diketo 
tautomeric form.  The infrared spectrum of this compound showed absorbances at 



























114 112  








Figure 11.  Infrared Spectrum of Dinitrosoorcinol  
 
     Facile O-alkylation of dinitrotoluene 113 using standard dimethyl sulfate 
conditions led to 3,5-dimethoxy-2,4-dinitrotoluene 115 in excellent yield.  Compound 
115 required only benzylic oxidation of the methyl group to an aldehyde to 
successfully synthesize our desired A ring intermediate.  Unfortunately, this oxidation 





























     Several oxidation schemes were envisioned to arrive at the desired aldehyde.  Our 
first attempts were guided by a recent seminar presented by Dr. Jotham Coe from 
Pfizer Inc.   Dr. Coe directed us to his recently published method of converting 
nitrotoluene derivatives to aldehydes, achieved by a two-step process of forming 
enamines with N,N-dimethylformamide dimethyl acetal and oxidative cleavage of 
that enamine to the desire aldehyde with sodium periodate.  This transformation was 
demonstrated on a variety of nitroarenes (Scheme 102), however none with the 
methoxy groups our substrate would require (Scheme 102). 
     Repeated attempts to produce enamine 116 via the Coe methodology on these 
systems however failed.  The conditions were modified to include amine bases as has 
been done by others,198,199 including pyrrolidine and Hunig’s base, however no 
enamine was detected.  In each case, the starting toluene 115 was consumed in the 
process, but the product always contained the toluene methyl group unfunctionalized. 
The likely product of this reaction was electrophilic aromatic substitution, however 
since this is clearly not the desired transformation, little effort was directed at 
characterizing this byproduct.  Further efforts at the direct benzylic oxidation of 115 
were attempted with known oxidation systems, including selenium dioxide and 













































     The final potential pathway to the dinitrated A ring precursor 103 that we explored 
involved the dinitrosation/oxidation on orcinol-like substrates that already included 
an oxidated toluene methyl carbon:  3,5-dihydroxybenzoic acid and methyl 3,5-
dihydroxybenzoate.  If either of these compounds regioselectively dinitrosated as 
orcinol did, the resulting benzoate or benzoic acid functionality could be selectively 
reduced.  This would need to be done in the presence of reducible nitro groups, 
however, the low-temperature reduction of esters to aldehydes by DIBAL is a 
































     Since none of our examined routes generated the desired dinitrobenzaldehyde #, 
the remaining efforts in this work were focused on the elaboration of the 
mononitrated A ring precursor benzaldehyde 102 into 2-pyridylquinolines. 
     Mononitrobenzaldehyde 102 was treated with the lithium acetylide of 2-ethynyl-
pyridine to form propargyl alcohol 96, in poor, unoptimized 18% yield.  This 
propargyl alcohol was then subjected to reductive cyclization conditions, producing 
































     The desired synthesis of the AB-quinolinequinone ring system of the antitumor 
antiobiotic streptonigrin has led to the development of a new methodology for 
synthesizing quinolines.  The utilization of o-nitrophenyl propargyl alcohols, 
produced either through direct lithium acetylide addition of available alkynes, or 
Sonogashira coupling to terminal propargyl alcohols, has led to the facile synthesis of 
2-aryl-, 2-alkenyl and 2-alkylquinolines via reductive cyclization under mildly acid 
conditions.  Several examples of this methodology have been produced, with a variety 
of electron-donating and electron-withdrawing substituents on the carbocyclic ring of 
quinoline, proving the versatility of the reductive cyclization.   
     The application of this methodology to the 2-pyridylquinoline system required to 
synthesize streptonigrin has identified an anomalous cyclization, leading to quinolone 
formation, instead of the desired quinoline.  This cyclization has been studied 
mechanistically, and several possible mechanisms have been proposed and evaluated.   
The evidence presented favors the rearrangement of the pyridyl-substituted propargyl 
alcohol to an enone derivative that is not capable of aromatizing to quinoline.  
Oxidative rearomatization leads to the observed quinolone.  Future efforts to apply 
this methodology to the synthesis of 2-pyridylquinoline must address this anomalous 
rearrangement.  One potential avenue to circumvent that rearrangement is the Meyer-
Schuster rearrangement catalyzed by a transition metal instead of acid.  Initial 
screening of rhenium-catalyzed Meyer-Schuster rearrangement134 on dimethoxy 
propargyl alcohol 105 produced enone 118 in excellent yield.  Although one attempt 




enone 119, the basic pyridine may have scavenged the catalytic amount of p-
toluenesulfonic acid required.  Further examination of this and other transition-metal 
catalyzed Meyer-Schuster rearrangements may open the door for a two-step reductive 































     Lastly, extensive efforts toward the synthesis of the proposed A-ring precursor, 
dimethoxydinitrobenzaldehyde were described.  Although this synthesis was not 
achieved, the benefit of its use in dramatically shortening the total synthesis of 
streptonigrin dictate further study.  The use of mononitrobenzaldehyde 102, although 
synthesized in this work in a high-yielding, one-step process, leaves the final 7-amino 


























































Streptonigrin, (1)  
 
     Another potential avenue not explored in this work includes the generation of 
trinitroorcinol, as described by Rao.
160
  Although this compound has the potential to 
be an explosive, the third nitro group would further activate it toward the enamine 
formation required for the Coe metholodogy to produce the aldehyde.  The third nitro 




competing electrophilic aromation substitution.  Lastly, once reduced, the third nitro 
group (now amino) would facilitate oxidation to the quinoline-quinone.  These 
features make this trinitroorcinol an intriguing, albeit potentially dangerous, A-ring 






































     Overall, the DeShong group’s progress toward the total synthesis of streptonigrin 
has been greatly advanced by this work.  With additional studies on the reductive 
cyclization of pyridyl-substituted propargyl alcohols, 2-pyridylquinolines can be 
produced, and thus the application of this quinoline heteroannulation should provide 












A solution of 3.66 mL (31.7 mmol) of 1-hexyne in 25 mL anhydrous THF was cooled 
to 0 °C, and 13.0 mL (26.0 mmol) of 2.0M n-butyl lithium was added dropwise.  The 
resulting solution was stirred for 30 min at 0 °C, and then 2.40 g (15.9 mmol) of o-
nitrobenzaldehyde dissolved in 5 mL anhydrous THF was added dropwise via 
cannula.  The mixture was stirred at 0 °C for a subsequent 60 min, then quenched 
with water.   The THF was removed in vacuo, and the residue was dissolved in 
diethyl ether, washed with water and brine, dried over MgSO4 and concentrated in 
vacuo.   Purification by filtration through a short column of silica gel with chloroform 
gave 3.64 g (98%) of 76 as a pale brown oil.   IR (thin film, NaCl) 3405 (br s), 3105 
(w), 3074 (w), 3039 (w), 2959 (s), 2934 (s), 2872 (s), 2277 (w), 2228 (w), 1609 (m), 
1579 (m), 1529 (s), 1352 (s), 1012 (s) cm-1; 1H NMR (CDCl3) ) 0.91, (t, J = 7 Hz, 
3H), 1.40 (m, 2H), 1.51 (m, 2H), 2.25 (dt, J = 2, 7 Hz, 2H), 3.05 (d, J = 6 Hz, 1H), 
5.97 (d, J = 6 Hz, 1H), 7.49 (t, J = 8 Hz, 1H), 7.67 (t, J = 8 Hz, 1H), 7.94 (d, J = 8 Hz, 
2H); 13C NMR (CDCl3) ) 13.5, 18.4, 21.9, 30.4, 61.5, 77.8, 88.2, 124.9, 129.1, 129.4, 
133.6, 136.0, 148.2; HRMS (FAB+, M+Li+) m/z for C13H15NO3Li












Produced by the same procedure as 76, using commercially available 6-
nitropiperonal. Column chromatography (chloroform, Rf = 0.26) yielded 77 as a pale 
orange oil (72%).  IR (thin film, NaCl) 3526 (br s), 3411 (br s), 3121 (w), 3068 (w), 
2958 (m), 2933 (m), 2872 (m), 2285 (w), 2228 (w), 1617 (m), 1524 (s), 1505 (s), 
1484 (s), 1333 (s), 1262 (s), 1035 (s), 930 (m), 883 (m); 1H NMR (CDCl3) ) 0.90 (t, J 
= 7 Hz, 3H), 1.39 (m, 2H), 1.50 (m, 2H), 2.24 (t, J = 7 Hz, 2H), 3.16 (br s, 1H), 5.95 
(s, 1H), 6.13 (s, 2H), 7.41 (s, 1H), 7.47 (s, 1H); 13C NMR (CDCl3) ) 13.5 18.4, 21.9, 
30.4, 61.3, 77.9, 87.9, 103.1, 105.7, 108.4, 133.6, 142.0, 147.6, 152.1; HRMS (FAB+, 
M+Li+) m/z for C14H15NO5Li








Produced by the same procedure as 76, using commercially available 5-chloro-2-
nitrobenzaldehyde.  Recrystallization of the crude solid from hexanes yielded 78 as a 
pale yellow solid, mp 43.5-44.5 ºC (59%).  IR (thin film, NaCl) 3531 (br s), 3417 (br 
s), 3103 (w), 2959 (m), 2934 (m), 2873 (m), 2279 (w), 2230 (m), 1603 (s), 1571 (s), 
1527 (s), 1466 (m), 1344 (s), 1078 (s), 843 (s); 1H NMR (CDCl3) ) 0.90 (t, J = 8 Hz, 
3H), 1.39 (m, 2H), 1.49 (m, 2H), 2.23 (t, J = 7 Hz, 2H), 3.03 (br s, 1H), 6.01 (s, 1H), 




88.6, 126.4, 129.0, 129.3, 138.1, 140.1, 146.1; Anal. calcd for C13H14NO3Cl:  C, 







Produced by the same procedure as 76, using commercially available 3-methoxy-2-
nitrobenzaldehyde.  Filtration of the crude reaction mixture through a short column of 
silica with chloroform yielded 79 as a pale orange oil (96%).  IR (thin film, NaCl) 
3529 (br s), 3406 (br s), 3094 (w), 3021 (w), 2958 (m), 2935 (m), 2873 (m), 2285 
(w), 2233 (w), 1607 (w), 1585 (m), 1535 (s), 1478 (m), 1370 (m), 1282 (s), 1024 (m), 
853 (m), 761 (m); 1H NMR (CDCl3) ) 0.90 (t, J = 8 Hz, 3H), 1.39 (m, 2H), 1.50 (m, 
2H), 2.24 (m, 2H), 2.71 (br s, 1H), 3.90 (s, 3H), 5.56 (s, 1H), 7.02 (d, J = 8 Hz, 1H), 
7.34 (d, J = 8 Hz, 1H), 7.45 (t, J = 8 Hz, 1H); 13C NMR (CDCl3) ) 13.7, 18.5, 22.1, 
30.5, 56.7, 61.3, 77.5, 88.8, 112.9, 119.9, 131.7, 134.6, 140.0, 151.3; HRMS (FAB+, 
M+Li+) m/z for C14H17NO4Li








Produced by the same procedure as 76, using commercially available 
2-nitroacetophenone.  Radial chromatography (4:1 hexanes/ethyl acetate, Rf = 0.40) 




2959 (m), 2934 (m), 2872 (m), 2244 (w), 1532 (s), 1364 (s), 1219 (m), 1108 (m), 
1083 (m), 917 (m), 855 (m), 779 (m), 750 (m); 1H NMR (CDCl3) ) 0.91 (t, J = 8 Hz, 
2H), 1.38 (m, 2H), 1.47 (m, 2H), 1.95 (s, 3H), 2.20 (t, J = 8 Hz, 2H), 3.34 (s, 1H), 
7.41 (dt, J = 1, 8 Hz, 1H), 7.54 (m, 2H), 7.80 (dd, J = 1, 8 Hz, 1H); 13C NMR 
(CDCl3) ) 13.5, 18.3, 22.0, 30.3, 31.3, 68.0, 81.7, 86.0, 124.4, 127.4, 128.6, 131.8, 
138.3, 149.8; HRMS (FAB+, M+Li+) m/z calcd for C14H17NO3Li







A solution of 2.60 mL (23.7 mmol) of phenylacetylene in 30 mL anhydrous THF was 
cooled to 0 °C, and 9.0 mL (18.0 mmol) of 2.0M n-butyl lithium was added dropwise.  
The resulting solution was stirred for 30 min at 0 °C, and then 2.45 g (16.2 mmol) of 
o-nitrobenzaldehyde dissolved in 5 mL anhydrous THF was added dropwise via 
cannula.  The mixture was stirred at 0 °C for a subsequent 60 min, then quenched 
with water.   The THF was removed in vacuo, and the residue was dissolved in 
diethyl ether, washed with water and brine, dried over MgSO4 and concentrated in 
vacuo.   Column chromatography (chloroform, Rf = 0.41) yielded 4.00 g (97%) of 80 
as a pale orange oil.  IR (thin film, NaCl) 3396 (br s), 3064 (w), 2922 (w), 2868 (w), 
2233 (w), 1652 (w), 1559 (w), 1525 (s), 1490 (m), 1348 (m), 1033 (m), 961 (m), 757 
(m), 691 (m); 1H NMR (CDCl3) ) 3.26 (d, J = 6 Hz, 1H), 6.21 (d, J = 6 Hz, 1H), 7.32 




= 1, 8 Hz, 2H); 13C NMR (CDCl3) ) 62.0, 86.5, 86.9, 121.0, 125.1, 128.3, 128.8, 
129.4, 129.6, 131.8, 133.8, 135.4, 148.2; HRMS (FAB+, M+Li+) m/z for 
C15H11NO3Li






Produced by the same procedure as 80, using commercially available 
2-nitroacetophenone.  Column chromatography (4:1 hexanes/ethyl acetate, Rf = 0.26) 
yielded 73 as a pale orange oil (72%).  IR (thin film, NaCl) 3527 (br s), 3081 (w), 
3057 (w), 2989 (w), 2935 (w), 2883 (w), 2235 (w), 1598 (w), 1530 (s), 1490 (s), 1362 
(s), 1070 (m), 854 (m), 757 (s), 691 (s); 1H NMR (CDCl3) ) 2.09 (s, 3H), 3.62 (s, 1H) 
7.31 (m, 3H), 7.43 (m, 3H), 7.60 (m, 2H), 7.87 (dd, J = 1, 8 Hz, 1H); 13C NMR 
(CDCl3) ) 30.9, 68.2, 84.8, 90.2, 121.8, 124.6, 127.3, 128.3, 128.7, 128.8, 131.8, 
132.0, 137.8, 149.8; HRMS (FAB+, M+Li+) m/z for C16H13NO3Li
+ calcd 274.1055, 






A solution of 1.18 mL (10.0 mmol) of 1-ethynylcyclohexene in 30 mL anhydrous 
THF was cooled to 0 °C, and 4.5 mL (9.0 mmol) of 2.0M n-butyl lithium was added 




temperature for an additional 30 min.  After recooling to 0 °C, 1.340 g (8.87 mmol) 
of o-nitrobenzaldehyde dissolved in 5 mL anhydrous THF was added dropwise via 
cannula.  The mixture was stirred at 0 °C for a subsequent 30 min, then quenched 
with water.   The THF was removed in vacuo, and the residue was dissolved in 
diethyl ether, washed with water and saturated aqueous ammonium chloride, dried 
over MgSO4 and concentrated in vacuo.  Column chromatography (chloroform, Rf = 
0.40) yielded 2.21g (97%) of 81 as a pale orange oil.  IR (thin film, NaCl) 3528 (br s), 
3416 (br s), 3111 (w), 3076 (w), 3028 (w), 2931 (s), 2859 (s), 2839 (m), 2218 (s), 
1609 (m), 1529 (s), 1349 (m), 1180 (m), 1052 (s), 980 (m), 920 (m), 858 (m), 786 
(m), 730 (m); 1H NMR (CDCl3) ) 1.59 (m, 4H), 2.10 (m, 4H), 3.15 (d, J = 6 Hz, 1H), 
6.07 (d, J = 6 Hz, 1H), 6.15 (m, 1H), 7.49 (t, J = 8 Hz, 1H), 7.66 (t, J = 8 Hz, 1H), 
7.93 (m, 2H); 13C NMR (CDCl3) ) 21.3, 22.1, 25.6, 28.8, 61.8, 83.8, 88.8, 119.7, 
124.9, 129.1, 129.5, 133.6, 135.7, 136.4, 148.2; HRMS (FAB+, M+Li+) m/z for 
C15H15NO3Li







A solution of 1.02 mL (10.0 mmol) of 2-ethynylpyridine in 30 mL anhydrous THF 
was cooled to 0 °C, and 4.5 mL (9.0 mmol) of 2.0M n-butyl lithium was added 
dropwise.  The resulting solution was stirred for 30 min at 0 °C, and warmed to room 
temperature for an additional 30 min.  After recooling to 0 °C, 1.27 g (8.40 mmol) of 




cannula.  The mixture was stirred at 0 °C for a subsequent 30 min, then quenched 
with water.   The THF was removed in vacuo, and the residue was dissolved in 
diethyl ether, washed with water and saturated aqueous ammonium chloride, dried 
over MgSO4 and concentrated in vacuo.  Column chromatography (diethyl ether, Rf = 
0.18) yielded 380 mg (18%) of 64 as a pale orange oil.  IR (thin film, NaCl) 3149 (br 
s), 2960 (w), 2935 (w), 2856 (w), 2253 (w), 2226 (w), 1588 (m), 1523 (s), 1471 (m), 
1350 (m), 1057 (m), 1037 (m), 861 (m), 782 (m); 1H NMR (CDCl3) ) 5.33 (br s, 1H), 
6.39 (s, 1H), 7.24 (m, 1H), 7.45 (m, 2H), 7.64 (m, 2H), 7.96 (dd, J = 1, 8 Hz, 1H), 
8.10 (d, J = 7 Hz, 1H), 8.52 (d, J = 5 Hz, 1H); 13C NMR (CDCl3) ) 60.6, 84.6, 88.6, 
123.4, 124.8, 127.6, 129.0, 129.1, 133.7, 135.6, 136.7, 142.2, 147.8, 149.5; HRMS 
(FAB+, M+Li+) m/z for C14H10N2O3Li







Produced by the same procedure as 64, using commercially available 2-
nitroacetophenone.  Column chromatography (7:3 hexanes/ethyl acetate, Rf = 0.06) 
yielded 83 as a pale orange oil (59%).  IR (thin film, NaCl) 3154 (br s), 2990 (m), 
2934 (m), 2866 (w), 2806 (w), 2245 (w), 1589 (s), 1529 (s), 1468 (m), 1362 (m), 
1280 (m), 1153 (m), 1110 (m), 908 (m), 855 (s), 780 (s), 738 (s); 1H NMR (CDCl3) ) 
2.10 (s, 3H), 4.60 (br s, 1H), 7.22 (m, 1H), 7.43 (m, 2H), 7.55-7.66 (m, 3H), 7.92 (d, J 




123.2, 124.4, 127.6, 127.7, 128.8, 131.9, 136.4, 137.7, 142.2, 149.5, 149.7; HRMS 
(FAB+, M+H+) m/z for C15H13N2O3
+ calcd 269.0926, found 269.0918. 
 




A solution of 1.00 g (6.62 mmol) of o-nitrobenzaldehyde in 40 mL anhydrous THF 
was cooled to 0 °C, and 17.6 mL (8.80 mmol) of 0.5M ethynylmagnesium bromide 
solution was added dropwise.  The resulting solution was stirred for 20 min at 0 °C, 
then quenched with water.   The THF was removed in vacuo, and the residue was 
dissolved in diethyl ether, washed with water and brine, dried over MgSO4 and 
concentrated in vacuo.  Radial chromatography (7:3 hexanes/ethyl acetate, Rf = 0.25) 
and recrystallization from chloroform yielded 1.13 g (96%) of 59 as an off-white 
solid, mp 54.0-55.5 ºC.  IR (thin film, NaCl) 3530 (br s), 3416 (br s), 3290 (s), 3109 
(w), 2927 (w), 2866 (w), 2121 (m), 1610 (m), 1579 (m), 1527 (s), 1349 (s), 1031 (s); 
1H NMR (CDCl3) ) 2.65 (s, 1H), 3.24 (br s, 1H), 6.02 (s, 1H), 7.52 (dt, J = 1, 8 Hz, 
1H), 7.69 (dt, J = 1, 8 Hz, 1H), 7.98 (dt, J = 1, 8 Hz, 2H); 13C NMR (CDCl3) ) ! 60.8, 
75.0, 81.4, 124.9, 129.1, 129.3, 133.8, 134.8, 147.7; Anal. calcd for C9H7NO3:  C, 









To a solution of 744 mg (4.20 mmol) of 59, and 872 mg (12.6 mmol) of imidazole in 
10 mL anhydrous CH2Cl2 was added 2.70 mL (12.6 mmol) of triisopropylsilyl 
chloride, and the solution was stirred at room temperature for 22 hours.  The mixture 
was dissolved in diethyl ether, washed with water and brine, dried over MgSO4 
concentrated in vacuo.   Recrystallization of the crude residue from pentane gave 1.19 
g (85%) of 61 as a pale orange solid, mp 57.5-58.5 °C.  IR (thin film, NaCl) 3311 
(m), 2946 (s), 2868 (s), 1533 (s), 1464 (w), 1351 (m), 1100 (m), 1065 (m), 883 (m); 
1H NMR (CDCl3) ) 1.06 (d, J = 7 Hz, 9H), 1.11 (d, J = 7 Hz, 9H), 1.21 (m, 3H), 2.46 
(d, J = 2 Hz, 1H), 6.32 (d, J = 2 Hz, 1H), 7.46 (dt, J = 1, 8 Hz, 1H), 7.68 (dt, J = 1, 8 
Hz, 1H), 8.00 (dd, J = 1, 8 Hz, 1H), 8.06 (d, J = 8 Hz, 1H); 13C NMR (CDCl3) ) 12.1, 
17.9, 60.5, 73.0, 83.1, 124.6, 127.9, 128.5, 133.7, 137.5, 146.7; Anal. calcd for C-






A solution of  3.00 g (19.9 mmol) of o-nitrobenzaldehyde in 100 mL anhydrous THF 
was cooled to 0 °C, and 51.6 mL (25.8 mmol) of 0.5M ethynylmagnesium bromide 
was added dropwise.  The resulting solution was stirred for 1h at 0 °C, then quenched 




diethyl ether, washed with water and saturated aqueous NaHCO3, dried over MgSO4 
and concentrated in vacuo.   The residue was then dissolved in 50 mL of CH2Cl2, and 
both 3.38 g (49.6 mmol) of imidazole and 3.59 g (23.8 mmol) of tert-
butyldimethylsilyl chloride were added.  The resulting mixture was stirred for 1h at 
room temperature, then washed with water, dried over MgSO4, and concentrated in 
vacuo.  Column chromatography (4:1 hexanes/ethyl acetate, Rf = 0.54) yielded 5.67 g 
(97 %) of 62 as a pale orange oil.  IR (thin film, NaCl) 3299 (s), 3105 (w), 3082 (w), 
2956 (s), 2930 (s), 2886 (m), 2858 (s), 2119 (w), 1609 (w), 1579 (w), 1532 (s), 1472 
(m), 1352 (s), 1255 (s), 1099 (s), 1069 (s), 841 (s), 781(s); 1H NMR (CDCl3) ) 0.17 
(s, 3H), 0.22 (s, 3H), 0.94 (s, 9H), 2.49 (d, J = 2 Hz, 1H), 6.22 (d, J = 2 Hz, 1H), 7.47 
(dt, J = 1, 8 Hz, 1H), 7.67 (dt, J = 1, 8 Hz, 1H), 7.97 (dd, J = 1, 8 Hz, 1H), 8.01 (d, J 
= 8 Hz, 1H); 13C NMR (CDCl3) ) -5.2, -4.7, 18.2, 25.7, 60.7, 73.6, 82.8, 124.6, 128.0, 
128.6, 133.5, 136.7, 147.0; HRMS (FAB+, M+Li+) m/z for C15H22NO3SiLi
+ calcd 
292.1369, found 292.1363. 
 




A solution of 3.00 g (19.9 mmol) of o-nitrobenzaldehyde in 100 mL anhydrous THF 
was cooled to 0 °C, and 51.6 mL (25.8 mmol) of 0.5M ethynylmagnesium bromide 
was added dropwise.  The resulting solution was stirred for 1h at 0 °C, then quenched 
with water.  The THF was removed in vacuo, and the residue was dissolved in diethyl 




concentrated in vacuo.  The residue was dissolved in 50 mL of CHCl3, and both 4.76 
mL (59.6 mmol) of pyridine and 2.44 mL (25.8 mmol) of acetic anhydride were 
added.  After the resulting mixture was stirred for 3h at room temperature, TLC 
showed incomplete protection, so acetic anhydride and pyridine were added (same 
amounts).  After another 2.5h, a third portion of acetic anhydride was required to 
complete the conversion.  The reaction mixture was concentrated in vacuo, dissolved 
with diethyl ether, washed with water, dried over MgSO4, and concentrated in vacuo.  
Column chromatography (4:1 hexanes/ethyl acetate, Rf = 0.24) yielded 3.71 g (85 %) 
of 63 as a pale orange solid, mp 60.0-61.0 ºC.  IR (thin film, NaCl) 3290 (s), 3110 
(w), 3081 (w), 3041 (w), 2870 (w), 2128 (m), 1751 (s), 1539 (s), 1350 (s), 1220 (s), 
1022 (s), 962 (s), 857 (s), 787 (s); 1H NMR (CDCl3) ) 2.12 (s, 3H), 2.68 (d, J = 2 Hz, 
1H), 7.04 (d, J = 2 Hz, 1H), 7.55 (dt, J = 1, 8 Hz, 1H), 7.70 (dt, J = 1, 8 Hz, 1H), 7.94 
(d, J = 8 Hz, 1H), 8.01 (d, J = 8 Hz, 1H); 13C NMR (CDCl3) ) 20.5, 61.5, 76.1, 78.7, 
124.9, 129.3, 129.8, 131.4, 133.6, 169.0; Anal. calcd for C11H9NO4:  C, 60.27; H, 







A solution of 200 mg (0.600 mmol) of 61, 0.10 mL (0.66 mmol) of 2-pyridyl triflate, 
14 mg (0.012 mmol) of tetrakistriphenylphosphine palladium(0), 2.3 mg (0.012 
mmol) of copper(I) iodide, and 0.21 mL (1.5 mmol) of triethylamine in 5 mL 




filtered through Celite, concentrated in vacuo, dissolved in diethyl ether, washed with 
water and brine, dried with MgSO4, and concentrated in vacuo.  Radial 
chromatography (7:3 hexanes/ethyl acetate, Rf = 0.47) yielded 199 mg (81%) of 65 as 
a pale orange oil.  IR (thin film, NaCl) 3076 (w), 3053 (w), 2945 (s), 2892 (m), 2867 
(s), 1582 (m), 1529 (s), 1464 (s), 1428 (m), 1351 (s), 1099 (s), 1064 (s), 883 (m), 780 
(m), 680 (m); 1H NMR (CDCl3) ) 1.09 (d, J = 7 Hz, 9H), 1.13 (d, J = 7 Hz, 9H), 1.26 
(m, 3H), 6.56 (s, 1H), 7.19 (m, 1H), 7.37 (d, J = 8 Hz, 1H), 7.45 (dt, J = 1, 8 Hz, 1H), 
7.60 (dt, J = 2, 8 Hz, 1H), 7.69 (dt, J = 1, 8 Hz, 1H), 8.00 (dd, J = 1, 8 Hz, 1H), 8.12 
(dd, J = 1, 8 Hz, 1H), 8.52 (d, J = 4 Hz, 1H); 13C NMR (CDCl3) ) 12.1, 17.9, 61.0, 
84.0, 88.4, 122.9, 124.6, 127.4, 128.3, 128.5, 133.7, 136.0, 137.3, 142.7, 146.6, 
149.9; HRMS (FAB+, M+H+) m/z for C23H31N2O3Si






A solution of 195 mg (3.49 mmol) of iron metal in 4 mL ethanol was heated to 80 °C, 
then 2 drops of concentrated HCl were added.  The mixture was stirred for 1h, then 
184 mg (0.727 mmol) of 80 dissolved in 4 mL ethanol was added, and stirred at 80 °C 
until the starting material was consumed, an additional 2h.  Then 1 mL of 10% aq. 
HCl was added, and the mixture stirred for an additional 25h, adding additional 1 mL 
aliquots of aq. HCl if the pH > 4.   The reaction mixture was quenched with saturated 




EDTA, dried with MgSO4, and concentrated in vacuo.  The resulting residue was 
redissolved in ether, washing with five 20 mL portions of 2% aq. HCl.  The combined 
aqueous layers were basified with solid NaHCO3, extracted with diethyl ether, dried 
with MgSO4, and concentrated in vacuo, yielding 96 mg (64%) of 88 as a white solid, 
mp 78.0-79.0 ºC.  1H NMR (CDCl3) ) 7.47 (m, 1H), 7.54 (m, 3H), 7.74 (m, 1H), 7.83 
(d, J = 8 Hz, 1H), 7.88 (d, J = 8 Hz, 1H), 8.17-8.24 (m, 4H); 13C NMR (CDCl3) 
) 119.0, 126.3, 127.2, 127.5, 127.6, 128.8, 129.3, 129.6, 129.8, 136.8, 139.7, 148.3, 





Produced by the same procedure as 88, using propargyl alcohol 73.  Column 
chromatography (9:1 hexanes/ethyl acetate, Rf = 0.42) yielded 75 as a pale yellow oil 
(82%).  IR (thin film, NaCl) 3061 (m), 3035 (w), 2979 (w), 2951 (w), 2921 (w), 1598 
(s), 1551 (s), 1509 (m), 1495 (m), 1451 (s), 1349 (s), 769 (s), 694 (s); 1H NMR 
(CDCl3) ) 2.76 (s, 3H), 7.48 (m, 1H), 7.55 (m, 3H), 7.72 (m, 2H), 8.00 (d, J = 8 Hz, 
1H), 8.20 (m, 3H); 13C NMR (CDCl3) ) 18.9, 119.7, 123.5, 125.9, 127.2, 127.5, 
128.7, 129.1, 129.2, 130.2, 139.8, 144.7, 148.1, 157.0; HRMS (EI+, M +) m/z for 
C16H13N









Produced by the same procedure as 88, using propargyl alcohol 77.  Crude residue 
was dissolved in hexane, and filtered.  Kugelrohr distillation (175 ºC, 10 mm Hg), 
yielded 85 as a pale orange solid (82%), mp 84.5-85.5 ºC.  IR (thin film, NaCl) 3042 
(w), 2957 (m), 2928 (m), 2856 (m), 1619 (m), 1514 (m) 1464 (s), 1240 (s), 1037 (m), 
940 (m), 853 (s), 733 (s); 1H NMR (CDCl3) ) 0.96 (t, J = 8 Hz, 3H), 1.43 (m, 2H), 
1.76 (m, 2H), 2.90 (t, J = 8 Hz, 2H), 6.08 (s, 2H), 7.02 (s, 1H), 7.14 (d, J = 8 Hz, 1H), 
7.34 (s, 1H), 7.86 (d, J = 8 Hz, 1H); 13C NMR (CDCl3) ) 14.0, 22.7, 32.3, 38.8, 
101.5, 102.6, 105.6, 119.5, 123.3, 135.0, 146.1, 147.1, 150.5, 160.8; HRMS (FAB+, 
M+H+) m/z for C14H16NO2





Produced by the same procedure as 88, using propargyl alcohol 79.  After acid/base 
extraction (same as 2-phenylquinoline), Kugelrohr distillation (175 ºC, 10 mm Hg) 
yielded 87 as a pale yellow oil (44%).  IR (thin film, NaCl) 3048 (w), 3000 (w), 2955 
(s), 2930 (s), 2871 (m), 2858 (m), 2834 (m), 1615 (m), 1603 (s), 1564 (s), 1503 (s), 
1472 (s), 1428 (s), 1378 (m), 1323 (m), 1259 (s), 1111 (s), 998 (m), 833 (m), 751 (m); 
1H NMR (CDCl3) ) 0.96 (t, J = 8 Hz, 3H), 1.45 (m, 2H), 1.80 (m, 2H), 3.03 (t, J = 8 
Hz, 2H), 4.07 (s, 3H), 7.02 (d, J = 8 Hz, 1H), 7.36 (m, 3H), 8.01 (d, J = 8 Hz, 1H); 




136.2, 139.9, 155.1, 162.4; HRMS (FAB+, M+H+) m/z for C14H18NO
+ calcd 






Produced by the same procedure as 88, using propargyl alcohol 78.  Crude residue 
was dissolved in hexane, and filtered.  Kugelrohr distillation (180 ºC, 10 mm Hg), 
yielded 86 as a pale yellow oil (68%).  IR (thin film, NaCl) 3055 (w), 2957 (s), 2929 
(s), 2871 (m), 2859 (m), 1599 (s), 1489 (s), 1073 (m), 876 (m), 831 (s); 1H NMR 
(CDCl3) ) 0.98 (t, J = 8 Hz, 3H), 1.45 (m, 2H), 1.79 (m, 2H), 2.96 (m, 2H), 7.31 (d, J 
= 8 Hz, 1H), 7.61 (dd, J = 4, 8 Hz, 1H), 7.75 (d, J = 4 Hz, 1H), 7.97 (d, J = 8 Hz, 1H); 
13C NMR (CDCl3) ) 14.0, 22.6, 32.0, 39.0, 122.2, 126.1, 127.2, 130.1, 130.4, 131.2, 
135.2, 146.3, 163.5; HRMS (FAB+, M+H+) m/z for C13H15ClN




N Bu  
A solution of 677 mg (2.90 mmol) of propargyl alcohol 76, 1.40 g (21.4 mmol) of 
zinc dust, 247 mg (4.62 mmol) of ammonium chloride in 15 mL ethanol/water (2:1 
v/v) was stirred at 85 °C for 4h.  Then 3 mL of glacial acetic acid was added, and the 
solution stirred for an additional 2h.  The reaction mixture was quenched with 




MgSO4, and concentrated in vacuo.  The resulting residue was redissolved in pentane, 
filtered, and the filtrate was concentrated in vacuo.  The residue was dissolved in 
diethyl ether, and washed with five 20 mL portions of 2% aq. HCl.  The combined 
aqueous layers were basified with solid NaHCO3, extracted with ethyl acetate, dried 
with MgSO4, and concentrated in vacuo, yielding 426 mg (79%) of 84 as a pale 
yellow oil.  IR (thin film, NaCl)  3057 (w), 2956 (s), 2929 (s), 2871 (m), 2859 (m), 
1617 (m), 1601 (s), 1503 (s), 1426 (m), 1310 (w), 1116 (w), 826 (s), 756 (s); 1H NMR 
(CDCl3) ) 0.97 (t, J = 8 Hz, 3H), 1.44 (m, 2H), 1.80 (m, 2H), 3.00 (t, J = 8 Hz, 2H), 
7.30 (m, 1H), 7.48 (m, 1H), 7.68 (m, 1H), 7.78 (d, J = 8 Hz, 1H), 8.05 (m, 2H); 13C 
NMR (CDCl3) ) 14.0, 22.7, 32.2, 39.1, 121.3, 125.6, 126.7, 127.4, 128.8, 129.3, 
136.1, 147.9, 163.1; HRMS (FAB+, M+H+) m/z for C13H16N







Produced by the same procedure as 84, using propargyl alcohol 81.  Crude residue 
dissolved in hexanes and filtered.  Kugelrohr distillation (165 ºC, 0.5 mm Hg) yielded 
89 as a pale orange oil (34%).  IR (thin film, NaCl)  3059 (m), 3037 (m), 2928 (s), 
2856 (s), 2830 (m), 1616 (m), 1598 (s), 1504 (s), 1428 (m), 1311 (w), 1231 (m), 820 
(s), 754 (s); 1H NMR (CDCl3) ) 1.73 (m, 2H), 1.85 (m, 2H), 2.33 (m, 2H), 2.72 (m, 
2H), 6.78 (m, 1H), 7.46 (t, J = 8 Hz, 1H), 7.57 (d, J = 8 Hz, 1H), 7.66 (dt, J = 1 & 8 




23.0, 26.2, 26.3, 118.1, 125.8, 127.1, 127.4, 129.4, 129.6, 130.5, 136.0, 137.9, 147.9, 
159.4; HRMS (FAB+, M+H+) m/z for C15H16N
+ calcd 210.1283, found 210.1286. 
 
2-Butyl-4-methylquinoline  74 
N Bu  
Tin Reduction:  A solution of 269 mg (1.09 mmol) of propargyl alcohol 72 and 736 
mg (3.26 mmol) of tin(II) chloride monohydrate in 6 mL ethanol was stirred at 80 °C 
for 2.5h.  Then 5 drops of concentrated HCl was added, and the solution stirred for an 
additional 2h.  The reaction mixture was quenched with saturated aqueous NaHCO3, 
dissolved in diethyl ether, washed with water, dried with MgSO4, and concentrated in 
vacuo.   Filtration through a short column of silica gel with 7:3 hexanes/ethyl acetate 
yielded 197 mg (91%) of 74 as a pale yellow oil.   
Zinc Reduction: A solution of 243 mg (0.98 mmol) of propargyl alcohol 72, 450 mg 
(6.88 mmol) of zinc dust, 168 mg (3.14 mmol) of ammonium chloride in 6 mL 
ethanol/water (2:1 v/v) was stirred at 85 °C for 2.5h.  Then 1 mL of glacial acetic acid 
was added, and the solution stirred for an additional 1h.  The reaction mixture was 
quenched with saturated aqueous NaHCO3, dissolved in diethyl ether, washed with 
water, dried with MgSO4, and concentrated in vacuo. Filtration through a short 
column of silica gel with 7:3 hexanes/ethyl acetate yielded 186 mg (95%) of 74 as a 
pale yellow oil.  IR (thin film, NaCl) 3061 (w), 3033 (w), 2956 (s), 2929 (s), 2871 
(m), 2859 (m), 1604 (s), 1562 (m), 1508 (m), 1448 (m), 758 (s) 1H NMR (CDCl3) ) 




Hz), 7.15 (s, 1H), 7.50 (m, 1H), 7.67 (m, 1H), 7.94 (d, J = 8 Hz, 1H), 8.04 (d, J = 8 
Hz, 1H); 13C NMR (CDCl3) ) 13.9, 18.6, 22.7, 32.1, 38.9, 122.0, 123.5, 125.3, 126.7, 
128.9, 129.3, 144.0, 147.7, 162.7; HRMS (EI+, M+) m/z for C14H17N









A solution of 100 mg (1.79 mmol) of iron metal in 3 mL ethanol was heated to 80 °C, 
then 2 drops of concentrated HCl were added.  The mixture was stirred for 1h, then 
119 mg (0.357 mmol) of 61 and 0.75 mL of saturated aqueous ammonium chloride 
were added, and stirred at 80 °C for an additional 19h.  The reaction mixture was 
quenched with saturated aqueous NaHCO3, dissolved in diethyl ether, washed with 
water, dried with MgSO4, and concentrated in vacuo.  Radial chromatography 
(chloroform) yielded 36 mg (33%) of 67 as a pale orange oil.  1H NMR (CDCl3) 
) 1.05 (d, 9H, J = 7 Hz), 1.10 (d, 9H, J = 7 Hz), 1.16 (m, 3H), 2.55 (s, 1H), 4.36 (br s, 
2H), 5.49 (s, 1H), 6.69 (m, 2H), 7.10 (m, 2H); 13C NMR (CDCl3) ) 12.1, 17.8, 65.2, 
72.9, 83.4, 116.7, 117.8, 125.1, 127.5, 129.0, 144.9; HRMS (EI+, M+) m/z for 
C18H29NOSi














A solution of 55 mg (1.0 mmol) of iron metal in 2 mL ethanol was heated to 80 °C, 
then 2 drops of concentrated HCl were added.  The mixture was stirred for 1h, then 
81 mg (0.20 mmol) of 64 dissolved in 2 ml of ethanol and 1.0 mL of saturated 
aqueous ammonium chloride were added, and stirred at 80 °C for an additional 35h.  
The reaction mixture was quenched with saturated aqueous NaHCO3, dissolved in 
diethyl ether, washed with water, dried with MgSO4, and concentrated in vacuo.  
Radial chromatography (7:3 hexanes/ethyl acetate, Rf = 0.41) yielded 23 mg (53%) of 
90 as an orange solid. IR (CCl4) 3354 (w), 3053 (w), 3010 (w), 2954 (w), 2923 (w), 
2855 (w), 2289 (m), 1707 (s), 1614 (s), 1549 (s), 1483 (s), 1469 (s), 1383 (m), 1253 
(s), 1217 (s), 1005 (m), 979 (m), 827 (br s); 1H NMR (CDCl3) ) 6.61 (s, 1H), 6.90 (t, 
1H, J = 8 Hz), 6.97 (d, 1H, J = 8 Hz), 7.15 (m, 1H), 7.38 (d, 1H, J = 8 Hz), 7.45 (t, 
1H, J = 7 Hz), 7.68 (m, 2H), 8.66 (d, 1H, J = 4 Hz), 9.95 (br s, 1H); 13C NMR 
(CDCl3) ) 105.3, 111.6, 120.2, 120.9, 121.6, 125.2, 126.3, 136.6, 136.7, 138.4, 149.4, 
153.3, 156.1, 187.9; HRMS (EI+, M+) m/z for C14H10N2O
+ calcd 222.0793, found 














A solution of 135 mg (2.42 mmol) of iron metal in 3 mL ethanol was heated to 80 °C, 
then 2 drops of concentrated HCl were added.  The mixture was stirred for 30 min, 
then 44 mg (0.14 mmol) of 96 was added, and stirred at 80 °C for an additional 12h.  
The reaction mixture was quenched with saturated, basic aqueous EDTA, dissolved in 
ethyl acetate, washed with basic EDTA, dried with MgSO4, and concentrated in 
vacuo.  Filtration of the crude reaction mixture through a short column of silica with 
1:1 ethyl acetate:hexanes yielded 31 mg (78%) of 117 as a purple powder.  IR (thin 
film, NaCl) 3381 (m), 3009 (w), 2925 (m), 1695 (s), 1620 (s), 1508 (s), 1468 (m), 
1439 (m), 1381 (s), 1279 (m), 1255 (m), 1150 (m), 1130 (s), 1044 (m), 933 (w), 
781(m); 1H NMR (CDCl3) ) 3.78 (s, 3H), 3.92 (s, 3H), 6.64 (m, 2H), 6.76 (d, 1H, J = 
2 Hz), 7.14 (m, 1H), 7.38 (d, 1H, J = 8 Hz), 7.66 (m, 1H), 8.69 (d, 1H, J = 5 Hz), 9.56 
(br s, 1H); 13C NMR (CDCl3) ) 55.9, 56.0, 96.8, 106.5, 107.6, 120.7, 121.6, 126.3, 











A mixture of 500 mg of claycop (cupric nitrate on Montmorillonite clay, prepared by 




of 3,5-dimethoxybenzaldehyde, and 10 drops of conc. HNO3 in 5 mL of diethyl ether 
was stirred at room temperature for 1.5h.  By TLC, starting material was not fully 
consumed, so an additional 10 drops of HNO3 was added, and the mixture stirred for 
an additional 1.5h.  The reaction mixture was filtered through a short column of silica 
with diethyl ether, then washed with water, dried with MgSO4, and concentrated in 
vacuo.  This crude residue was primarily #, with some gem-diacetate # also.  The 
mixture was dissolved in chloroform, and ~ 10g of silica gel and 1 mL of 3N H2SO4 
were added.  This mixture was stirred at room temperature for 6h, then filtered, 
washed with water, and concentrated in vacuo.  Column chromatography 
(chloroform), followed by recrystallization from hexanes yielded 191 mg (87%) of 
102 as an off-white solid, mp 97.0-99.0 ºC.  IR (thin film, NaCl) 3308 (w), 3018 (w), 
2978 (w), 2943 (w), 2892 (w), 2845 (w), 1703 (s), 1589 (s), 1534 (s), 1462 (m), 1340 
(m), 1311 (m), 1201 (m), 1038 (w), 959 (m), 842 (s); 1H NMR (CDCl3) ) 3.92 (s, 
3H), 3.94 (s, 3H), 6.77 (d, 1H, J = 2 Hz), 6.97 (d, 1H, J = 2 Hz), 9.95 (s, 1H); 13C 
NMR (CDCl3) ) 56.2, 56.8, 104.3, 104.8, 130.5, 135.4, 153.2, 162.1, 186.8.  
Characterization data matched those reported by Chang.192 
 








Produced by the same procedure as 102, without the HNO3.  Column chromatography 
(7:3 hexanes/ethyl acetate, Rf = 0.17) yielded 104 (24%) as a white solid.  IR (thin 




1462 (m), 1366 (m), 1204 (m), 1015 (m); 1H NMR (CDCl3) ) 2.12 (s, 6H), 3.87 (s, 
3H), 3.89 (s, 1H), 6.56 (d, 1H, J = 2 Hz), 6.60 (d, 1H, J = 2 Hz), 7.72 (s, 1H); 13C 
NMR (CDCl3) ) 20.6, 56.0, 56.8, 86.6, 100.4, 103.9, 130.8, 133.8, 153.4, 161.7, 
168.4.  
 








A mixture of 64 mg of claycop, 0.25 mL (2.7 mmol) of acetic anhydride, 42 mg (0.13 
mmol) of 104 in 1 mL of diethyl ether was stirred at room temperature for 16h.  The 
reaction mixture was filtered through a short column of silica with diethyl ether, then 
washed with water, dried with MgSO4, and concentrated in vacuo.  This crude residue 
was primarily unreacted 104, however, column chromatography (1:1 hexanes/ethyl 
acetate) yielded trace amounts of 107.  Regiochemistry of second nitro group 
unconfirmed, but inferred from symmetry of NMR spectra.  IR (thin film, NaCl) 3114 
(w), 3026 (w), 2925 (s), 2853 (m), 1781 (s), 1601 (s), 1545 (s), 1437 (m), 1364 (s), 
1223 (s), 1192 (s), 1066 (m), 1017 (s), 831 (m), 760 (m); 1H NMR (CDCl3) ) 2.09 (s, 
6H), 3.98 (s, 6H), 6.67 (s, 1H), 7.64 (s, 1H); 13C NMR (CDCl3) ) 20.2, 57.1, 84.0, 











Produced by the same procedure as 76, using 3,5-dimethoxy-2-nitrobenzaldehyde 
102. Column chromatography (chloroform, Rf = 0.20) yielded 105 as a pale brown oil 
(77%).  IR (thin film, NaCl) 3516 (br s), 3102 (w), 2955 (s), 2936 (s), 2873 (s), 2285 
(w), 2235 (m), 1610 (s), 1536 (m), 1464 (m), 1330 (m), 1202 (m), 1167 (m), 1119 
(m), 1012 (m), 929 (m), 844 (s); 1H NMR (CDCl3) ) 0.86 (t, 3H, J = 7 Hz), 1.36 (m, 
2H), 1.46 (m, 2H), 2.20 (t, 2H, J = 7 Hz), 3.83 (s, 6H), 5.55 (m, 1H), 6.45 (d, 1H, J = 
2 Hz), 6.83 (d, 1H, J = 2 Hz); 13C NMR (CDCl3) ) 13.6, 18.4. 22.0, 30.4, 55.8, 56.6, 






A solution of 440 mg (7.88 mmol) of iron metal in 5 mL ethanol was heated to 80 °C, 
then 5 drops of concentrated HCl were added.  The mixture was stirred for 30 min, 
then 292 mg (1.00 mmol) of 105 dissolved in 3 mL ethanol was added, and stirred at 
80 °C for 20h.  The reaction mixture was quenched with saturated aqueous NaHCO3, 
dissolved in diethyl ether, washed with saturated, basic aqueous EDTA, dried with 
MgSO4, and concentrated in vacuo. The residue was dissolved in chloroform, and 
washed with five 20 mL portions of 5% aq. HCl.  The combined aqueous layers were 




combined ether layers were dried with MgSO4, and concentrated in vacuo, yielding 
200 mg (82%) of 106 as a pale yellow oil.  IR (thin film, NaCl) 3009 (m), 2956 (s), 
2932 (s), 2871 (m), 2858 (m), 1625 (s), 1621 (s), 1614 (s), 1570 (s), 1466 (m), 1386 
(m), 1201 (s), 1122 (s), 1051 (m), 839 (s); 1H NMR (CDCl3) ) 0.93 (t, 3H, J = 7 Hz), 
1.42 (m, 2H), 1.75 (m, 2H), 2.96 (t, 2H, J = 8 Hz), 3.87 (s, 3H), 4.01 (s, 3H), 6.60 (d, 
1H, J = 2 Hz), 6.67 (d, 1H, J = 2 Hz), 7.26 (d, 1H, J = 8 Hz), 7.88 (d, 1H, J = 8 Hz); 
13C NMR (CDCl3) ) 14.1, 22.9. 32.4, 39.0, 55.5, 56.2, 96.9, 101.1, 122.1, 128.3, 









A solution of 1.33 g (8.00 mmol) of 3,5-dimethoxybenzaldehyde in 40 mL of 
methanol and 60 mL of methylene chloride was stirred at room temperature, then a 
solution of 3.90 g (8.00 mmol) tetrabutylammonium tribromide in 10 mL of the same 
2:3 MeOH/CH2Cl2 solution was added dropwise.  After addition, this mixture stirred 
at room temperature for 24h.  The crude reaction mixture was extracted with ethyl 
acetate, washed with water, dried with MgSO4, and concentrated in vacuo.  Crude 
NMR showed a 2:1 mixture of 108 and its dimethyl acetal, so the crude residue was 
dissolved in CH2Cl2, and 3.3 g of Montmorillonite K-10 clay was added.  This 
mixture stirred for 10 min, until the dimethyl acetal was no longer observed by TLC 
(CHCl3, Rf = 0.36), then filtered through Celite, and concentrated in vacuo.  




105.0-106.0 ºC.  1H NMR (CDCl3) ) 3.84 (s, 3H), 3.90 (s, 3H), 6.69 (d, 1H, J = 3 
Hz), 7.02 (d, 1H, J = 3 Hz), 10.39 (s, 1H); 13C NMR (CDCl3) ) 55.8, 56.6, 103.4, 
105.8, 109.1, 134.7, 157.0, 159.9, 192.0.  Anal. calcd for C9H9BrO3:  C, 44.11; H, 














A solution of 4.97 g (35.0 mmol) of orcinol monohydrate in 84 mL of 0.5M NaOH 
was cooled to 0 °C, then 4.90 g (70 mmol) of sodium nitrite was added, followed by 
the slow dropwise addition of 37.5 mL of 6M H2SO4 over 1h.  Early drops added ca.  
5/min.  Visible evolution of brown gas was observed if acid is added too quickly.  
Once 50% of the acid is added, remaining acid can be added more quickly.  After the 
solution stirred for an additional hour at 0 °C, a brown precipitate formed.  The 
precipitate was filtered, washed with water, and dried under high vacuum, yielding a 
brown powder.  Attempts to recrystallize this powder from water, or water/methanol 
solutions resulted in decomposition, therefore the crude 112 was carried forward 
without purification.  IR (solid) 3518 (w), 3138 (br m), 2770 (br m), 1695 (w), 1646 
(m), 1597 (m), 1536 (m), 1385 (s), 1046 (s), 927 (s), 878 (s), 792 (s); 1H NMR 
(acetone-d6) ) 2.29 (s, 3H), 6.55 (s, 1H); 
13C NMR (acetone-d6) ) 19.0, 127.8, 146.9, 












A solution of crude dinitrosoorcinol 112 (35 mmol) in 80 mL of trifluoroacetic acid 
was cooled to 0 ºC, and 12 mL (~117 mmol) of 30% aqueous hydrogen peroxide was 
added dropwise.  After 4h of stirring, the solution was carefully concentrated in vacuo 
to remove most of the trifluoroacetic acid, then was washed with water, extracted 
with ethyl acetate, dried with MgSO4, and concentrated in vacuo.   Recrystallization 
from chloroform yielded 3.64 g (49% from orcinol) of 113 as yellow crystals (X-ray 
crystallographic analysis data included in Appendix), mp 159.0-160.0 ºC.  IR (solid) 
3229 (m), 1635 (m), 1580 (s), 1519 (s), 1359 (s), 1304 (s), 1164 (s), 850 (m); 1H 
NMR (Acetone-d6) ) 2.43 (s, 3H), 6.68 (s, 1H), 10.93 (br s, 1H), 11.14 (br s, 1H); 
13C 
NMR (Acetone-d6) ) 19.9, 111.8, 126.5, 133.4, 141.6, 149.4, 156.0.  Anal. calcd for 









A solution of 776 mg (3.62 mmol) of dinitroorcinol 113, 1.83 g (13.2 mmol) of 
potassium carbonate in 30 mL acetone was stirred at room temperature, then 1.03 mL 
(10.9 mmol) of dimethyl sulfate was added.  The reaction mixture was heated to 
reflux for 4h.  After cooling to room temperature, and concentration in vacuo, the 




with MgSO4, and concentrated in vacuo.  Recrystallization from hexanes yielded 800 
mg (91%) of 115 as off-white needles, mp 92.0-92.5 ºC, IR (thin film, NaCl) 3101 
(w), 2988 (w), 2953 (m), 2860 (m), 1600 (s), 1536 (s), 1468 (s), 1361 (s), 1336 (s), 
1225 (s), 1121 (s), 922 (m), 830 (m), 666 (s); 1H NMR (CDCl3) ) 2.39 (s, 3H), 3.94 
(s, 3H), 3.95 (s, 3H), 6.65 (s, 1H); 13C NMR (CDCl3) ) 18.6, 57.1, 64.4, 109.3, 134.5, 
135.2, 139.5, 145.9, 152.5.  Anal. calcd for C9H10N2O6:  C, 44.63; H, 4.16; N, 11.57, 








A solution of 200 mg (0.682 mmol) of 105, 34 mg (0.068 mmol) of 
tetrabutylammonium perrhenate, and 13 mg (0.068 mmol) of p-toluenesulfonic acid 
monohydrate in 5 mL CH2Cl2 was stirred at room temperature for 16h.  The crude 
mixture was dissolved in diethyl ether, washed with saturated aqueous NaHCO3, 
dried with MgSO4, and concentrated in vacuo, yielding 182 mg (91%) of 118 as a 
yellow solid.  IR (thin film, NaCl) 3103 (w), 2958 (s), 2937 (s), 2873 (m), 1696 (m), 
1667 (m), 1592 (s), 1526 (s), 1342 (s), 1207 (s), 1170 (s), 1089 (m), 969 (m), 840 
(m); 1H NMR (CDCl3) ) 0.91 (t, 3H, J = 7 Hz), 1.35 (m, 2H), 1.61 (m, 2H), 2.63 (t, 
2H, J = 7 Hz), 3.85 (s, 3H), 3.87 (s, 3H), 6.55 (d, 1H, J = 2 Hz), 6.61-6.65 (m, 2H), 
7.37 (d, 1H, J = 16 Hz); 13C NMR (CDCl3) ) 14.0, 22.4, 26.2, 40.2, 56.0, 56.7, 101.0, 
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Crystal Structure Information for UM # 1575
Issued by: Peter Y. Zavalij  
Crystal No. & ID : 1575: DeShong/Sandelier MJS-I-85Y
Compound name : Organic compound
Chemical formula : C7H6N2O6
Final R1 [I>2!(I)] : 3.70 %
"""""""""""""""""""""""""""""""""""""""""""
Figure 1. A view of UM#1575 showing the numbering scheme employed. Anisotropic atomic displacement 
ellipsoids for the non-hydrogen atoms are shown at the 30% probability level. Hydrogen atoms are displayed with 
an arbitrarily small radius.
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A yellow prism of C7H6N2O6, approximate dimensions 0.11!0.21!0.26 mm3, was used for the X-ray 
crystallographic analysis. The X-ray intensity data were measured at 298(2) K on a three-circle diffractometer 
system equipped with Bruker Smart1000 CCD area detector using a graphite monochromator and a MoK" fine-
focus sealed tube (#= 0.71073 Å) . The detector was placed at a distance of 4.939 cm from the crystal.
A total of 3024 frames were collected with a scan width of 0.3° an exposure time of 23 sec/frame using 
SMART (Bruker, 1999). The total data collection time was 25.3 hours. The frames were integrated with SAINT 
software package using a narrow-frame integration algorithm. The integration of the data using a Monoclinic unit 
cell yielded a total of 8148 reflections to a maximum $  angle of 27.50°, of which 1954 were independent 
(completeness = 99.6%, Rint = 2.43%, Rsig = 1.67%) and 1568 were greater than 2%(I). The final cell dimensions of a
= 7.157(2) Å, b = 12.348(4) Å, c = 10.056(3) Å, " = 90°, & = 105.800(5)°, ' = 90°, V  = 855.1(4) Å3, are based upon 
the refinement of the XYZ-centroids of 3466 reflections with 2.7 < $ < 29.0° using SAINT software. Analysis of the 
data showed 0 % decay during data collection. Data were corrected for absorption effects with the Semi-empirical 
from equivalents method using SADABS (Sheldrick, 1996). The minimum and maximum transmission coefficients 
were 0.915 and 0.984.
The structure was solved and refined using the SHELXS-97 (Sheldrick, 1990) and SHELXL-97 (Sheldrick, 
1997) software in the space group P21/n with Z = 4 for the formula unit C7H6N2O6. The final anisotropic full-matrix 
least-squares refinement on F2 with 156 variables converged at R1 = 3.70 % for the observed data and wR2 = 7.46 % 
for all data. The goodness-of-fit was 1.000. The largest peak on the final difference map was 0.202(e/Å3 and the 
largest hole was -0.164(e/Å3. On the basis of the final model, the calculated density was 1.663 g/cm3 and F(000), 
440(e.
Overall structure quality considerations:
1.  Strong data set, no disorder, R1 4% maximum. Publishable quality.
2.  Good data set, perhaps some minor disorder, R1 6% maximum. Publishable quality.
3.  Average data set and/or easily modeled disorder or twinning. Publishable with care.
4.  Weak data and/or major disorder or twinning that is not easily modeled. Publishable in some cases.
5.  Very weak data and/or unexplained features of data or model. Not of publishable quality.
A structure with a quality factor of 4 or 5 should not be used for a regulatory document without prior consultation.
Comments:
- Data quality: very good
- Twinning: none 
- Disorder: moderate - CH3 and 1 of 2 NO2 group show rotation disorder; 
the former in about 3:2 ratio and the latter in about 10:1 ratio
- H-atoms: constrained geometry as riding on attached atom (A) 
except H atoms of hydroxyl groups which were refined freely; 
Uiso refined
- Residual density: in the middle of the bonds 
- Structure quality: very good 
Publishable Yes 
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Table 1. Crystal data and structure refinement for UM#1575.
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
 X-ray lab book No. 1575
 Crystal ID DeShong/Sandelier MJS-I-85Y
 Empirical formula C7H6N2O6
 Formula weight 214.14
 Temperature 298(2) K
 Wavelength 0.71073 Å
 Crystal size 0.26"0.21"0.11 mm3
 Crystal habit yellow prism
 Crystal system monoclinic
 Space group P21/n
 Unit cell dimensions a = 7.157(2) Å # = 90°
b = 12.348(4) Å $ = 105.800(5)°
c = 10.056(3) Å % = 90°
 Volume 855.1(4) Å3
 Z 4
 Density, &calc 1.663 g/cm
3
 Absorption coefficient, µ 0.149 mm-1
 F(000) 440'e
 Diffractometer Bruker Smart1000 CCD area detector
 Radiation source fine-focus sealed tube, MoK#
 Detector distance 4.939 cm 
 Data collection method ( and scans 
 Total frames 3024
 Frame size 512 pixels 
 Frame width 0.3°
 Exposure per frame 23 sec
 Total measurement time 25.3 hours
) range for data collection 3.13 to 27.50°
 Index ranges -9 * h *  9, -16 * k *  15, -12 * l *  13
 Reflections collected 8148
 Independent reflections 1954
 Observed reflection, I>2+(I) 1568
 Coverage of independent reflections 99.6 %
 Variation in check reflections 0 %
 Absorption correction Semi-empirical from equivalents
SADABS (Sheldrick, 1996)
 Max. and min. transmission 0.984 and 0.915
 Structure solution technique direct
 Structure solution program SHELXS-97 (Sheldrick, 1990)
 Refinement technique Full-matrix least-squares on F2
 Refinement program SHELXL-97 (Sheldrick, 1997)
 Function minimized ,w(Fo
2 - Fc
2)2
 Data / restraints / parameters 1954 / 3 / 156
 Goodness-of-fit on F2 1.000
-/+max 0.000
 Final R indices: R1,   I>2+(I) 0.0370
wR2, all data 0.0746
Rint 0.0243
Rsig 0.0167
 Weighting scheme w = 1/[+2(Fo
2)+ (0.01P)2 + 0.393P],
P = [max(Fo
2 ,0) + 2Fo
2]/3
Extinction coefficient 0.0227(13)
 Largest diff. peak and hole 0.202 and -0.164'e/Å3
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!





Table 2. Atomic coordinates and equivalent* isotropic atomic displacement parameters (Å2) for  UM#1575.
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
Atom x/a y/b z/c Ueq
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
  O1 0.34608(14) 0.10075(9) 0.66217(11) 0.0539(3)
  O2 1.02283(15) -0.00639(10) 0.75387(12) 0.0619(3)
  N1 0.38064(16) 0.23084(9) 0.45880(12) 0.0473(3)
  O3 0.3246(2) 0.30416(12) 0.51937(18) 0.0701(5)
  O4 0.3066(3) 0.20886(13) 0.33733(15) 0.0728(5)
  N1A 0.38064(16) 0.23084(9) 0.45880(12) 0.0473(3)
  O3A 0.373(3) 0.3237(9) 0.494(2) 0.0701(5)
  O4A 0.249(2) 0.1850(12) 0.3763(17) 0.0728(5)
  N2 0.66373(18) -0.02168(10) 0.83297(12) 0.0500(3)
  O5 0.50146(17) -0.03530(10) 0.85109(12) 0.0693(3)
  O6 0.81017(17) -0.06278(10) 0.91123(11) 0.0673(3)
  C1 0.52287(17) 0.10239(10) 0.64144(13) 0.0386(3)
  C2 0.68367(18) 0.04275(10) 0.71925(12) 0.0398(3)
  C3 0.86199(18) 0.04758(11) 0.68548(14) 0.0439(3)
  C4 0.87566(19) 0.11050(11) 0.57492(14) 0.0463(3)
  C5 0.72180(18) 0.17067(10) 0.49729(13) 0.0419(3)
  C6 0.54841(17) 0.16611(10) 0.53433(13) 0.0391(3)
  C7 0.7471(2) 0.23866(13) 0.37993(15) 0.0556(4)
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
*
 Ueq is defined as one third of the trace of the orthogonalized Uij tensor.
Table 2a.  Site occupancy factors that deviate from unity for UM#1575.
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
Atom sof Atom sof Atom sof
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
N1 0.910(4) O3 0.910(4) O4 0.910(4)
N1A 0.090(4) O3A 0.090(4) O4A 0.090(4)
H7A 0.632(15) H7B 0.632(15) H7C 0.632(15)
H7D 0.368(15) H7E 0.368(15) H7F 0.368(15)
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
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Table 3.  Anisotropic atomic displacement parameters* (Å2) for UM#1575.
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
Atom U11 U22 U33 U23 U13 U12
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
  O1 0.0421(5) 0.0609(6) 0.0643(6) 0.0031(5) 0.0237(5) 0.0015(5)
  O2 0.0434(5) 0.0732(7) 0.0659(7) 0.0199(6) 0.0094(5) 0.0107(5)
  N1 0.0434(6) 0.0420(6) 0.0536(7) 0.0000(5) 0.0084(5) 0.0026(5)
  O3 0.0647(10) 0.0643(8) 0.0798(10) -0.0116(7) 0.0169(7) 0.0231(7)
  O4 0.0831(10) 0.0641(9) 0.0537(8) -0.0025(7) -0.0115(7) 0.0168(7)
  N1A 0.0434(6) 0.0420(6) 0.0536(7) 0.0000(5) 0.0084(5) 0.0026(5)
  O3A 0.0647(10) 0.0643(8) 0.0798(10) -0.0116(7) 0.0169(7) 0.0231(7)
  O4A 0.0831(10) 0.0641(9) 0.0537(8) -0.0025(7) -0.0115(7) 0.0168(7)
  N2 0.0575(7) 0.0499(7) 0.0424(6) -0.0001(5) 0.0134(5) -0.0045(6)
  O5 0.0689(7) 0.0812(8) 0.0668(7) 0.0144(6) 0.0338(6) -0.0055(6)
  O6 0.0712(7) 0.0726(7) 0.0516(6) 0.0181(5) 0.0055(5) 0.0024(6)
  C1 0.0360(6) 0.0388(6) 0.0419(6) -0.0078(5) 0.0123(5) -0.0027(5)
  C2 0.0435(6) 0.0393(6) 0.0366(6) -0.0016(5) 0.0112(5) -0.0033(5)
  C3 0.0377(6) 0.0451(7) 0.0458(7) -0.0010(6) 0.0063(5) 0.0018(5)
  C4 0.0369(6) 0.0530(8) 0.0513(7) 0.0021(6) 0.0161(6) 0.0006(6)
  C5 0.0437(7) 0.0412(7) 0.0417(7) -0.0018(5) 0.0130(5) -0.0014(5)
C6 0.0373(6) 0.0378(6) 0.0404(6) -0.0024(5) 0.0072(5) 0.0021(5)
  C7 0.0617(9) 0.0554(9) 0.0543(8) 0.0085(7) 0.0236(7) 0.0007(7)
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
* The anisotropic atomic displacement factor exponent takes the form:-2"2 [ h2a*2U11 +... + 2hka*b*U12 ]
Table 4.  Hydrogen atom coordinates and isotropic atomic displacement parameters (Å2) for UM#1575.
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
Atom x/a y/b z/c Uiso
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
  H1 0.354(3) 0.0546(16) 0.727(2) 0.085(6)
  H2 0.997(3) -0.0413(16) 0.819(2) 0.089(7)
  H4 0.9930 0.1124 0.5519 0.051(4)
  H7A 0.8828 0.2442 0.3853 0.056(4)
  H7B 0.6952 0.3097 0.3855 0.056(4)
  H7C 0.6797 0.2056 0.2938 0.056(4)
  H7D 0.6223 0.2621 0.3245 0.056(4)
  H7E 0.8099 0.1967 0.3242 0.056(4)
  H7F 0.8254 0.3007 0.4159 0.056(4)
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
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Table 5.  Bond lengths (Å), valence and torsion angles (°) for UM#1575.
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
O1-C1 1.3373(15) O1-H1 0.859(19) O2-C3 1.3457(16)
O2-H2 0.84(2) N1-O3 1.2185(16) N1-O4 1.2222(16)
N1-C6 1.4700(16) N2-O5 1.2351(16) N2-O6 1.2354(15)
N2-C2 1.4318(17) C1-C6 1.3855(18) C1-C2 1.4102(17)
C2-C3 1.4084(18) C3-C4 1.3815(19) C4-C5 1.3805(18)
C5-C6 1.3906(18) C5-C7 1.4989(19)
C1-O1-H1 105.2(13) C3-O2-H2 108.1(13) O3-N1-O4 123.53(14)
O3-N1-C6 118.66(13) O4-N1-C6 117.80(12) O5-N2-O6 121.26(12)
O5-N2-C2 119.72(12) O6-N2-C2 119.03(12) O1-C1-C6 117.42(11)
O1-C1-C2 124.72(12) C6-C1-C2 117.86(11) C3-C2-C1 120.03(12)
C3-C2-N2 120.66(11) C1-C2-N2 119.31(11) O2-C3-C4 116.84(12)
O2-C3-C2 124.13(13) C4-C3-C2 119.02(12) C5-C4-C3 122.50(12)
C4-C5-C6 117.35(12) C4-C5-C7 119.85(12) C6-C5-C7 122.80(12)
C1-C6-C5 123.20(11) C1-C6-N1 116.64(11) C5-C6-N1 120.17(11)
O1-C1-C2-C3 177.80(12) C6-C1-C2-C3 -1.15(18) O1-C1-C2-N2 -2.68(19)
C6-C1-C2-N2 178.36(11) O5-N2-C2-C3 -171.41(13) O6-N2-C2-C3 8.50(19)
O5-N2-C2-C1 9.07(19) O6-N2-C2-C1 -171.01(12) C1-C2-C3-O2 179.94(12)
N2-C2-C3-O2 0.4(2) C1-C2-C3-C4 -0.58(19) N2-C2-C3-C4 179.91(12)
O2-C3-C4-C5 -179.30(13) C2-C3-C4-C5 1.2(2) C3-C4-C5-C6 0.0(2)
C3-C4-C5-C7 179.05(13) O1-C1-C6-C5 -176.60(12) C2-C1-C6-C5 2.44(19)
O1-C1-C6-N1 3.44(17) C2-C1-C6-N1 -177.52(11) C4-C5-C6-C1 -1.88(19)
C7-C5-C6-C1 179.10(13) C4-C5-C6-N1 178.09(12) C7-C5-C6-N1 -0.93(19)




Table 7.  Hydrogen bond information for UM#1575 (Å and °).
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
 D!H…A* d(D!H) d(H…A) d(D…A) "(DHA)
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
 O1!H1…O5 0.859(19) 1.783(19) 2.5529(17) 148.0(18)
 O1!H1…O2#1 0.859(19) 2.568(19) 3.0190(17) 113.8(15)
 O2!H2…O6 0.84(2) 1.85(2) 2.5723(17) 143.7(19)
 O2!H2…O3A#2 0.84(2) 2.50(2) 3.217(13) 144.1(18)
 O2!H2…O3#2 0.84(2) 2.61(2) 3.242(2) 133.2(17)
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
 * D - donor atom, H - hydrogen, A - acceptor.
 Symmetry transformation codes:#1 x-1,y,z    #2 -x+3/2,y-1/2,-z+3/2    
Table 8. Least-squares planes (x,y,z in crystal coordinates) and angles between planes 
(* indicates atom used to define plane)
_____________________________________________________________________________
- 0.2090 (0.0058) x + 10.0695 (0.0061) y + 5.6728 (0.0063) z = 4.3679 (0.0057) 
 *   -0.0001 (0.0003)  C2
 *    0.0004 (0.0010)  N2
 *   -0.0002 (0.0004)  O5
 * -0.0001 (0.0004)  O6
 Rms deviation of fitted atoms =   0.0002
_____________________________________________________________________________
  0.8625 (0.0038) x + 9.5630 (0.0049) y + 5.6790 (0.0046) z = 5.0831 (0.0029) 
 Angle to previous plane (with approximate esd) =  9.24 ( 0.09 )
 *   -0.0103 (0.0008)  C1
 *   -0.0001 (0.0009)  C2
 *    0.0081 (0.0009)  C3
 *   -0.0062 (0.0010)  C4
 *   -0.0043 (0.0009)  C5
 *    0.0128 (0.0009)  C6
      0.0012 (0.0023)  C7
     -0.0607 (0.0018)  O1
      0.0192 (0.0020)  O2
      0.0582 (0.0019)  N1_a
      0.0582 (0.0019)  N1A_b
      0.0125 (0.0019)  N2
     -0.1550 (0.0023)  O5
      0.1901 (0.0022)  O6
 Rms deviation of fitted atoms =   0.0081
_____________________________________________________________________________
  5.1574 (0.0045) x + 7.8642 (0.0123) y - 4.6247 (0.0145) z = 1.6620 (0.0086) 
 Angle to previous plane (with approximate esd) = 65.80 ( 0.08 )
 *    0.0015 (0.0003)  C6
 *   -0.0053 (0.0011)  N1_a
 *    0.0019 (0.0004)  O3_a
 *    0.0019 (0.0004)  O4_a
 Rms deviation of fitted atoms =   0.0031
_____________________________________________________________________________
139
- 4.7615 (0.0430) x - 3.0682 (0.1646) y + 8.6333 (0.0714) z = 1.4809 (0.0809) 
 Angle to previous plane (with approximate esd) = 33.84 ( 0.87 )
 *    0.0113 (0.0021)  C6
 *   -0.0406 (0.0075)  N1A_b
 *    0.0146 (0.0027)  O3A_b
 *    0.0147 (0.0027)  O4A_b
 Rms deviation of fitted atoms =   0.0235
_____________________________________________________________________________
  0.8625 (0.0038) x + 9.5630 (0.0049) y + 5.6790 (0.0046) z = 5.0831 (0.0029) 
 Angle to previous plane (with approximate esd) = 80.53 ( 0.66 )
 *   -0.0103 (0.0008)  C1
 *   -0.0001 (0.0009)  C2
 *    0.0081 (0.0009)  C3
 *   -0.0062 (0.0010)  C4
 *   -0.0043 (0.0009)  C5
 *    0.0128 (0.0009)  C6
      0.0012 (0.0023)  C7
     -0.0607 (0.0018)  O1
      0.0192 (0.0020)  O2
      0.0582 (0.0019)  N1_a
      1.0549 (0.0023)  O3_a
     -0.9057 (0.0023)  O4_a
      0.0582 (0.0019)  N1A_b
      1.1405 (0.0113)  O3A_b
     -0.9625 (0.0115)  O4A_b
      0.0125 (0.0019)  N2
     -0.1550 (0.0023)  O5
      0.1901 (0.0022)  O6
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